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ABSTRACT
The Conserved Mechanism of IcsA Polar Targeting Among Proteobacteria, 
Characterization of the Omptin Family, and the Roles 
and Regulation of IcsP in Shigella flexneri
by
Eun-Hae Kim
Dr. Helen J. Wing, Examination Committee Chair 
Assistant Professor of Life Sciences 
University o f Nevada, Las Vegas
Shigella flexneri is a gram-negative intracellular pathogen that is a global health 
problem, causing severe bacillary dysentery. In the past 30 years, research has enabled 
us to have a better understanding of the molecular basis of Shigella pathogenesis. In this 
study, we further expand our knowledge of key determinants at molecular and cellular 
levels. This work is composed of four separate investigations.
Firstly, we examined whether the elusive mechanism of protein targeting found in 
Shigella is conserved in three closely related y-proteobacterial families by using GPP 
fusions and microscopy. Our results indicate that the mechanism of protein localization 
to the bacterial pole was conserved in the species investigated. Secondly, we further 
characterized omptin proteins found in three pathogenic organisms: Shigella (IcsP), E. 
coli (OmpT), and Salmonella  (PgtE). We addressed whether the LPS environment and/or 
the inherent amino acid differences in the surface loops and LPS binding motif affect the 
cleavage specificity of these proteases by introducing a known substrate into each of 
these strains and comparing cleavage patterns by western blot analysis. Our results
III
indicate that the cleavage specificity of these omptins are likely due to the inherent amino 
acid differences in the surface loops and/or LPS binding region. Thirdly, we examined 
whether IcsP, an outer membrane protease in Shigella, promotes resistance to a cationic 
antimicrobial peptide, LL-37 by using minimum inhibitory concentration assays. Our 
results suggest that IcsP does not promote resistance to LL-37. Finally, we examined 
whether icsP was regulated by RyhB, a small regulatory RNA, by western blot analysis 
and (3-galactosidase assays. Our results suggest that RyhB does not down-regulate the 
expression of icsP in S. flexneri.
Taken together, this study has improved our understanding of Shigella 
pathogenesis and omptin family proteases. Ultimately, the relevance o f this study has 
potential use for the development of prevention and intervention strategies against 
specific bacterial infections and disease.
IV
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CHAPTER 1
GENERAL INTRODUCTION
1.1 The genus Shigella 
Shigella was first discovered by the Japanese scientist Shiga in the 1890s and was 
adopted as a genus in the 1950s. The genus Shigella is part of the Enterobacteriaceae, a 
family that includes intestinal bacteria, which contains other genera such as Escherichia, 
Salmonella, and Yersinia. Historically, Shigella was first described as Bacillus 
dysenteriae, the causative agent of bacillary dysentery. At the time, it was understood 
that Shigella was closely related to Bacillus (now Escherichia) coli but was categorized 
into its own genus because B. coli was considered to be a commensal organism (Pupo et 
al., 2000). Shigellae can be categorized based on the results of a few biochemical assays. 
Some of the determining factors for differentiating Shigella from Escherichia are the 
inability o f Shigella to produce gas from glucose fermentation and inability to ferment 
lactose. Generally, compared to Escherichia, Shigella is less active in its utilization of 
carbohydrates (Lan et a l,  2002). Additionally, Shigella is non-motile while most strains 
of Escherichia are motile by peritrichous flagella. Tests for DNA homology show that 
strains of Shigella have 70% or higher genom ic homology with Escherichia coli (Brenner 
et a l ,  1972). Consequently, in today’s classification system. Shigella spp. would be 
considered Escherichia. However, the conventional nomenclature for Shigella spp., 
justified on historical and clinical grounds will be used throughout this thesis.
1
In the genus Shigella, there are four different species that are differentiated based 
on their 0-antigen of their lipopolysaccharide. The four species include: S. dysenteriae 
(13 serotypes), S. boydii (18 serotypes), S. sonnei (1 serotype), and S. flexneri ( 6  
serotypes) (Sansonetti, 2001). Relatively few biochemical properties are used to separate 
the species. However, mannitol fermentation, indole production, and ornithine 
decarboxylation can be used to differentiate some of the species. 5. sonnei is grouped by 
being mannitol and ornithine positive, while S. dysenteriae is negative for both. S. 
flexneri and S. boydii are both positive for mannitol fermentation but negative for 
decarboxylation of ornithine. To differentiate S. flexneri from S. boydii, O serotyping is 
essential (Lan et al., 2002).
1.2 Epidemioloev of Shisella spp.
Shigella spp. cause one o f the most communicable o f bacterial dysenteries, 
shigellosis. Shigella is highly infectious, with ingestion of as few as 10 to 100 cells 
resulting in disease (DuPont et a l ,  1989). The transmission of Shigella occurs via the 
fecal-oral route and commonly occurs in developing nations where poor hygiene and 
limited access to clean drinking water promote the spread o f enteric diseases. It is 
estimated that about 164 million people worldwide contract shigellosis annually and 1.1 
million cases result in death from the disease, mostly in children under 5 years o f age 
(Kotloff et a l, 1999). In the United States alone, the Centers for Disease Control 
estimates that approximately 448,200 total cases occur annually. Because of malnutrition 
and the lack o f proper medical attention in young children and the elderly infected with 
Shigella, mortality rates are high. The emergence of multi-drug resistant Shigella strains
contributes partly to the continuous high disease incidence rates (Sansonetti, 2006). 
Consequently, shigellosis remains an unresolved global health problem.
Deadly epidemics in developing nations are generally attributed to S. dysenteriae, 
while S. flexneri and S. sonnei are primarily responsible for endemic disease in developed 
nations. 5. boydii remains a problem in areas restricted to the Indian subcontinent. In 
this work, studies focus primarily on S. flexneri.
1.3 Pathogenesis of Shigella flexneri 
Shigella flexneri is a gram-negative facultative intracellular pathogen. The 
pathogenesis of S. flexneri is a multi-step process that is based on the ability of the 
bacterium to invade and replicate within host colonic epithelial cells, causing severe 
destruction o f host cells and inflammation. Following ingestion via the fecal-oral route. 
Shigella survives as it passes through the acidic environment o f the stomach because 
Shigella possesses effective acid resistance systems (Gorden et a l ,  1993). Subsequently, 
Shigella reaches the colon and rectum, where it accesses the intestinal mucosa. Shigella 
does not invade the apical side o f the colonic epithelium but exploits microfold cells (M 
cells), the specialized epithelial cells in the follicular associated epithelium that overlie 
lymphoid tissue (Wassef et a l,  1989) (Figure 1). These specialized cells continuously 
sample particles and microorganisms from the gut lumen and deliver them to the 
underlying mucosal lymphoid tissue (Neutra et a l, 1992; Man et a l,  2004).
As Shigella is released into the intraepithélial area, it encounters resident 
macrophages that function to engulf and degrade foreign material. Macrophages engulf 
Shigella, but instead of successfully destroying the bacterium. Shigella rapidly induces
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apoptosis o f the macrophage (Zychlinsky et a l, 1992). IpaB, a secreted effector 
molecule encoded on the Shigella virulence plasmid, is sufficient to induce macrophage 
apoptosis by binding and activating caspase-1 (Chen et a l,  1996). Caspases are 
intracellular cysteine proteases that induce mammalian cell apoptosis (Miura et a l, 
1993). Caspase-1 dependent apoptosis is not an immunologically silent death, because 
once caspase- 1  is activated, it is able to cleave and activate its specific substrates, 
interleukin-ip (IL-ip) and lL-18, into their biologically active form (Chen et a l,  1996; 
Dinarello,1998; Hilbi et a l ,  1998).
During macrophage cell death, proinflammatory cytokines, IL -lp  and IL-18 are 
released. Both o f these cytokines are crucial mediators involved in the massive 
inflammatory response induced by 5. flexneri (Zychlinsky et a l ,  1994; Sansonetti et a l,  
2000). The massive inflammatory response involves the recruitment of 
polymorphonuclear cells (PMNs) that transmigrate through the epithelial lining to reach 
the bacteria (Beatty et a l ,  1997). As a result of transmigration, this infiltration of PMNs 
towards the infected site destabilizes the epithelium. The influx of PMNs across the 
epithelial layer, in response to the presence of Shigella disrupts the integrity o f the 
epithelium allowing lumenal bacteria to traverse into the sub epithelial space and 
ultimately permit the organisms to access the basolateral surface o f the epithelial cells 
(Perdomo et a l ,  1994). Ironically, PMN-mediated interruption o f the barrier function 
contributes to the local spread of Shigella, although the objectives o f PMNs are to restrict 
the infection and prevent systemic dissemination.
In order to invade the intestinal mucosa, bacterial pathogens must find a site of 
entry. Once released from the macrophage, S. flexneri is able to invade the basolateral
surface o f colonie epithelial cells. It has been proposed that the basolateral membrane of 
epithelial cells displays cellular components that are utilized by Shigella as cell adhesion 
receptors (Jennison et al., 2004). Once attached, effector molecules are secreted into the 
host cell through the type III secretion apparatus. These effector molecules induce the 
rearrangement o f the host cell cytoskeleton at the site of hacterial-host cell interaction 
(Blocker et a i ,  1999). This mechanism, similar to macrophage and polymorphonuclear 
leukocyte phagocytosis, entails localized and transient actin polymerization and the 
accumulation o f myosin at the site o f entry for the bacteria (Clerc et a l ,  1987a). This 
leads to the formation o f large membrane protrusions within the colonic epithelial cell, 
which forms a macropinocytic pocket enclosing the bacterium (Tran Van Nhieu et a l, 
1999).
After triggering its uptake into host cells. Shigella is encased in an endocytic 
vacuole called the phagosome. Shigella can escape by lysing the surrounding membranes 
of the phagosome and as a result, is released into the cytosol, where it grows and divides 
(Clerc et a l ,  1987b). Lysis o f the membrane is dependent on the expression o f the 
mxi/spa and ipa genes to produce the type III secretion apparatus and the Ipa secretory 
effectors, specifically IpaC (Finlay et a l ,  1988). O f the Ipa proteins, IpaC is the 
significant factor for mediating escape from the phagosome. IpaC disrupts the integrity 
of phospholipid vesicles, thereby mediating membrane lysis (Harrington et a l,  2006). 
Once in the cytosol, the bacteria are contained within the epithelial cell, and are 
consequently protected from immune cells. This intracellular residence of Shigella 
ultimately provides a favorable environment for replication.
After bacteria escape the phagosome, Shigella quickly recruits filamentous actin 
to the bacterial pole (Bernardini et a i ,  1989). Recruitment of actin at the bacterial pole, 
mediated by the outer membrane protein IcsA (Bernardini et a i ,  1989; Goldberg et a l, 
1993; Goldberg et a l ,  1995), results in actin tail formation on the surface o f Shigella. 
This process propels Shigella through the cytoplasm and into adjacent cells and is 
essential for intercellular and intracellular spread (Makino et al., 1986).
1.4 Signs, symptoms, and treatment of shigellosis 
Shigellosis is concentrated in the colonic mucosal layer and results in severe 
tissue damage and ulceration. Destruction of this layer leads to the symptoms of 
shigellosis, which can vary from mild watery diarrhea to severe inflammatory dysentery. 
These symptoms can be described as severe abdominal cramps, fever, and blood present 
in mucoid stools. Usually shigellosis is self-limiting, however in immuno-compromised 
patients, if  left untreated, patients can develop critical complications such as septicemia 
and hemolytic uremic syndrome (Bennish, 1991). Successful treatment o f patients with 
shigellosis incorporates an intensive regimen o f antibiotics and hydration. 
Fluoroquinolones, broad-spectrum antibiotics, are highly effective against Shigella. 
Therefore, fluoroquinolones have become the preferred agent for the treatment of 
shigellosis (Hooper et a l ,  1985). Fluoroquinolones kill bacteria by binding to DNA 
gyrase, a type II topoisomerase, and thereby inhibiting DNA replication. Currently, there 
is no vaccine against Shigella, but candidate shigellosis vaccines, both killed and live 
attenuated are under development and are being tested in different clinical phases (World 
Health Organization, 2008).
1.5 Objectives of this study 
The aim o f this work is to improve our understanding o f the molecular basis of 
Shigella pathogenesis and the characterization of the omptin family o f proteases, which is 
present in several pathogenic organisms. This thesis is divided into two main chapters 
(chapter 2 and 3) encompassing four objectives.
Objective 1: To determine whether the mechanism of polar targeting found in 
Shigella is conserved in three closely related families in the y-proteobacteria. 
This objective is addressed in chapter 2.
Objective 2: To further characterize the omptin proteins found in three pathogenic 
organisms. Shigella flexneri (IcsP), Escherichia coli (OmpT), and Salmonella 
typhimurium (PgtE). The beginning of chapter 3 expands on this objective.
Obiective 3: To determine whether IcsP, an outer membrane protease, plays an 
additional role in the pathogenesis of S. flexneri by promoting resistance to a 
cationic antimicrobial peptide, LL-37. This objective is addressed in chapter 3.
Obiective 4: To determine whether icsP is regulated by a small regulatory RNA, 
RyhB. This objective is addressed in the end of chapter 3.
1. 6  References
Beatty W.L., and Sansonetti P.J. (1997) Role of lipopolysaccharide in signaling to 
subepithelial polymorphonuclear leukocytes. Infect Immun 65: 4395-4404.
Bennish M.L. (1991) Potentially lethal complications of shigellosis. Rev Infect Dis 13 
Suppl 4: S319-24.
Bernardini M.L., Mounier J., d'Hauteville H., Coquis-Rondon M., and Sansonetti P.J. 
(1989) Identification of icsA, a plasmid locus of Shigella flexneri that governs bacterial 
intra- and intercellular spread through interaction with F-actin. Proc Natl Acad Sci U S A  
8 6 : 3867-3871.
Blocker A., Gounon P., Larquet E., Niebuhr K., Cabiaux V., Parsot C., and Sansonetti P.
(1999) The tripartite type III secreton of Shigella flexneri inserts IpaB and IpaC into host 
membranes. J  Ce// Biol 147: 683-693.
Brenner D.J., Fanning G.R., Skerman F.J., and Falkow S. (1972) Polynucleotide 
sequence divergence among strains o f Escherichia coli and closely related organisms. J  
Bacteriol 109: 953-965.
Chen Y., Smith M.R., Thirumalai K., and Zychlinsky A. (1996) A bacterial invasin 
induces macrophage apoptosis by binding directly to ICE. EMBO J  \S: 3853-3860.
Clerc P., and Sansonetti P.J. (1987a) Entry of Shigella flexneri into HeLa cells: Evidence 
for directed phagocytosis involving actin polymerization and myosin accumulation. Infect 
Immun 55: 2681-2688.
Clerc P.L., Ryter A., Mounier J., and Sansonetti P.J. (1987b) Plasmid-mediated early 
killing o f eucaryotic cells by Shigella flexneri as studied by infection o f J774 
macrophages. Infect Immun 55: 521-527.
Dinarello C.A. (1998) Interleukin-1 beta, interleukin-18, and the interleukin-1 beta 
converting enzyme. Ann N  Y Acad Sci 856: 1-11.
DuPont H.L., Levine M.M., Hornick R.B., and Formal S.B. (1989) Inoculum size in 
shigellosis and implications for expected mode of transmission. J  Infect Dis 159: 1126- 
1128.
Finlay B.B., and Falkow S. (1988) Comparison of the invasion strategies used by 
Salmonella cholerae-sxxh. Shigella flexneri and Yersinia enterocolitica to enter cultured 
animal cells: Endosome acidification is not required for bacterial invasion or intracellular 
replication. Biochimie 70: 1089-1099.
Goldberg M.B., and Theriot J.A. (1995) Shigella flexneri surface protein IcsA is 
sufficient to direct actin-based motility. Proc Natl Acad Sci U S A  92: 6572-6576.
Goldberg M.B., Barzu O., Parsot C., and Sansonetti P.J. (1993) Unipolar localization and 
ATPase activity of IcsA, a Shigella flexneri protein involved in intracellular movement. 
Infect Agents Dis 2:210-211.
Gorden J., and Small P.L. (1993) Acid resistance in enteric bacteria. Infect Immun 61: 
364-367.
Harrington A., Darboe N., Kenjale R., Picking W.L., Middaugh C.R., Birket S., and 
Picking W.D. (2006) Characterization o f  the interaction o f  single tryptophan containing 
mutants o f IpaC from Shigella flexneri with phospholipid membranes. Biochemistry 45: 
626-636.
Hilbi H., Moss J.E., Hersh D., Chen Y., Arondel J., Banerjee S., et al. (1998) Shigella- 
induced apoptosis is dependent on caspase-1 which binds to IpaB. J  Biol Chem 273: 
32895-32900.
Hooper D.C., and Wolfson J.S. (1985) The fluoroquinolones: Pharmacology, clinical 
uses, and toxicities in humans. Antimicrob Agents Chemother 28: 716-721.
Jennison A.V., and Verma N.K. (2004) Shigella flexneri infection: Pathogenesis and 
vaccine development. FEMS Microbiol Rev 28: 43-58.
Kotloff K.L., Winickoff J.P., Ivanoff B., Clemens J.D., Swerdlow D.L., Sansonetti P.J., 
et al. (1999) Global burden o ï Shigella infections: Implications for vaccine development 
and implementation o f control strategies. Bull World Health Organ 77: 651-666.
Lan R., and Reeves P R. (2002) Escherichia coli in disguise: Molecular origins of 
Shigella. Microbes Infect 4: 1125-1132.
Makino S., Sasakawa C., Kamata K., Kurata T., and Yoshikawa M. (1986) A genetic 
determinant required for continuous reinfection of adjacent cells on large plasmid in S. 
flexneri 2a. Cell 46: 551-555.
Man A.L., Prieto-Garcia M.E., and Nicoletti C. (2004) Improving M cell mediated 
transport across mucosal barriers: Do certain bacteria hold the keys? Immunology 113: 
15-22.
Miura M., Zhu H., Rotello R., Hartwieg E.A., and Yuan J. (1993) Induction o f apoptosis 
in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans 
cell death gene ced-3. Cell 75: 653-660.
Neutra M.R., and Kraehenbuhl J.P. (1992) Transepithelial transport and mucosal defence 
I: The role of M cells. Trends Cell Biol 2: 134-138.
Perdomo J.J., Gounon P., and Sansonetti P.J. (1994) Polymorphonuclear leukocyte 
transmigration promotes invasion of colonic epithelial monolayer by Shigella flexneri. J  
Clin Invest 93: 633-643.
Pupo G.M., Lan R., and Reeves P.R. (2000) Multiple independent origins of Shigella 
clones o f Escherichia coli and convergent evolution of many of their characteristics. Proc 
Natl Acad Sci U S A 9 1 \  10567-10572.
Sansonetti P.J. (2006) Shigellosis: An old disease in new clothes? PLoS Med 3: e354.
1 0
Sansonetti P.J. (2001) Microbes and microbial toxins: Paradigms for microbial-mucosal 
interactions III. shigellosis: From symptoms to molecular pathogenesis. Am J  Physiol 
Gastrointest Liver Physiol 280: G319-23.
Sansonetti P.J., Phalipon A., Arondel J., Thirumalai K., Banerjee S., Akira S., et al.
(2000) Caspase-1 activation o f IL-1 beta and IL-18 are essential for Shigella flexneri- 
induced inflammation. Immunity 12: 581-590.
Tran Van Nhieu G., Caron E., Hall A., and Sansonetti P.J. (1999) IpaC induces actin 
polymerization and filopodia formation during Shigella entry into epithelial cells. EMBO 
y  18: 3249-3262.
Wassef J.S., Keren D.F., and Mailloux J.L. (1989) Role o f M cells in initial antigen 
uptake and in ulcer formation in the rabbit intestinal loop model o f shigellosis. Infect 
Immun 57: 858-863.
World Health Organization. (2008) Initiative for vaccine research (IVR). vaccine 
development.
Zychlinsky A., Prévost M.C., and Sansonetti P.J. (1992) Shigella flexneri induces 
apoptosis in infected macrophages. Nature 358: 167-169.
Zychlinsky A., Fitting C., Cavaillon J.M., and Sansonetti P.J. (1994) Interleukin 1 is 
released by murine macrophages during apoptosis induced by Shigella flexneri. J  Clin 
Invest 1328-1332.
11
CHAPTER 2
THE CONSERVED MECHANISM OF ICSA TARGETING TO THE BACTERIAL
POLE IN PROTEOBACTERIA
2.1 Introduction
This chapter addresses whether a mechanism of protein targeting, found in 
Shigella is conserved among other Y:proteobacteria. In this study we examine whether 
the mechanism of polar targeting, used by the polar protein IcsA found in Shigella, is 
conserved in species o f the Enterobacteriaceae, Vibrionaceae, and Pseudomonadaceae 
families.
Asymmetric localization of proteins is essential for many biological functions in 
bacteria. Bacteria must indulge in efficient, economical metabolic processes if they are 
to survive. Consequently, they have evolved their own strategies to seek out nutrients 
and to survive a variety of environments. These strategies may encompass chemotaxis, 
cell division, motility, adhesion, and pathogenesis. Although bacterial cells are small in 
size and lack discrete cellular compartments such as organelles, they have an elaborate 
internal structure of organization that is important for many of these fundamental 
processes to occur (Callaway, 2008). This internal organization requires specific proteins 
to localize to discrete locations within the bacterial cell. Thus, many bacterial proteins 
have sub-cellular addresses.
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Bacteria are capable of sorting and delivering proteins to specific sites within the 
cell with exquisite precision, yet bacterial cells lack transport vesicles, a golgi apparatus 
and an endoplasmic reticulum, which comprise the transport machinery in eukaryotic 
cells. How proteins reach their sub-cellular destination within bacterial cells remains 
unclear.
Examples of localized proteins can be found in Caulobacter crescentus, 
Pseudomonas aeruginosa, Myxococcus xanthus, and Shigella flexneri. In bacteria, the 
essential cell division protein FtsZ localizes to the cell midpoint early in cytokinesis 
where it assembles a cytokinetic ring (Donachie, 1993). Without the proper positioning 
of FtsZ, normal septation cannot occur (Ma et a l,  1996). Caulobacter crescentus 
expresses many chemosensory receptor proteins that localize to the flagellated cell pole 
(Alley et a l,  1992). Proper positioning of these proteins is necessary for chemotaxis (Liu 
et a l ,  1997). Another example of protein targeting can be found in Pseudomonas 
aeruginosa, which has a polar flagellum. For proper motility to occur, all flagellar 
proteins need to be localized to the pole for flagellar assembly. Myxococcus xanthus 
utilizes polar type IV pili and adhesion complexes for gliding motility (Wall et a l,  1999). 
During vegetative growth, cells swarm to find prey bacteria or to gather nutrients in the 
environment utilizing these polar proteins for motility. Consequently, the localization 
and coordination of this polar motility apparatus is essential for bacteria to show directed 
motility (Mauriello et a l,  2007). All these observations establish that protein localization 
plays a critical cellular role and that bacterial organization is highly complex.
The S. flexneri asymmetrically located outer membrane protein, IcsA, nucleates 
actin tail assembly in the host cytoplasm. Actin tail formation allows Shigella to move
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throughout the host cytoplasm and into adjacent cells. IcsA is classified as an 
autotransporter protein, which utilizes the type V secretion pathway (Brandon et a l,  
2003).
Autotransporters are the largest family of secreted virulence-associated proteins 
of gram-negative bacteria and are secreted in a type V secretion manner. These large 
proteins share a common domain organization that includes an amino-terminal signal 
peptide, a conserved carboxy-terminal translocation domain that forms a ^-barrel in the 
outer membrane, and a divergent functional domain that is exposed on the bacterial 
surface (Oomen et a l,  2004). Secretion of autotransporter proteins by the type V 
secretion pathway involves export through the cytoplasmic membrane via the Sec 
machinery. Once through the inner membrane, the signal sequence is cleaved and the p- 
domain inserts into the outer membrane as a P-barrel structure that forms a pore in the 
outer membrane. After formation of the P-barrel, the passenger domain is translocated 
onto the bacterial cell surface (Henderson et a l, 2004).
Once embedded in the outer membrane at the bacterial pole, IcsA recruits host 
actin. Proper positioning of IcsA to the old pole is necessary for the accumulation of 
short actin filaments into an F-actin comet tail (Bernardini et a l, 1989). Consequently, 
accurate placement of IcsA is necessary for Shigella virulence and contributes to its 
intracellular lifestyle.
Maintenance of IcsA at the bacterial pole is significant for Shigella virulence. 
IcsA has been shown to diffuse laterally along the sides o f Shigella away from the old 
pole (Steinhauer et a l,  1999). To maintain IcsA at the pole, an outer membrane protease 
called IcsP cleaves IcsA by proteolytically cleaving and releasing the amino terminal
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domain o f IcsA into the extracellular environment. The released amino terminal domain 
contains the determinant for actin tail formation. In mutants that lack IcsP, IcsA is 
observed to exist in small amounts over the entire bacterial surface (Egile et a l ,  1997; 
Shere et a l ,  1997). Additionally, in a strain expressing a non-cleavable form of IcsA, 
localization o f IcsA occurs over the entire bacterial surface and leads to the formation of 
abnormal F-actin comet tails in infected cells (d'Hauteville et a l ,  1996). Therefore, 
cleavage of IcsA by IcsP appears to be important in the maintenance o f an IcsA polar 
cap.
The mechanism of polar targeting of IcsA to the bacterial pole is not fully 
understood. However, there are several proposed mechanisms of IcsA polar targeting in 
Shigella. In the first proposed mechanism, targeted insertion, IcsA is directly and 
selectively inserted into the membrane at the site where it will ultimately reside. The 
second proposed mechanism, selective degradation, includes the random insertion of 
IcsA all over the membrane followed by the degradation of IcsA from locations other 
than its correct destination by proteases that are spatially restricted within the cell. In the 
third proposed mechanism, diffusion and capture, IcsA is inserted randomly into all 
membranes and becomes localized by diffusion to the site where it ultimately resides. Of 
these proposed mechanisms, targeted insertion has been shown to be the mechanism by 
which the outer membrane protein, IcsA achieves polar localization (Steinhauer et a l, 
1999; Charles et a l,  2001).
Charles et al. (2001) have shown that IcsA is localized to the bacterial pole and is 
targeted to the old pole within the cytoplasm of Shigella. Translational fusions between 
portions o f IcsA and GFP were used to determine the regions o f IcsA that are necessary
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for its targeting to the bacterial old pole. GFP is a cytoplasmic protein that cannot be 
secreted through the Sec apparatus, therefore these experiments, utilizing IcsA-GFP 
fusions addressed whether targeting occurred within the cytoplasm. Two sequences 
within IcsA, residues 1-104 and residues 507-620 are sufficient for IcsA localization to 
the pole in the bacterial cytoplasm. Interestingly, an IcsA-GFP fusion that lacks a signal 
peptide, localized to the old pole, indicating that signal peptide-mediated secretion is not 
required for localization to occur. IcsA-GFP fusions were also expressed in other types 
of bacteria to determine whether the mechanism of polar targeting to the bacterial pole is 
conserved. Charles et al. (2001) observed that the IcsA-GFP fusions target to the 
bacterial pole in V. cholerae and a variety of Enterobacteriacae, including E. call, S. 
typhimurium, Y. pseudotuberculosis. This chapter expands on a third y-proteobacterial 
family, the Pseudomonadaceae and addresses whether the mechanism of polar targeting 
to the bacterial pole is conserved in this family.
2.2 Materials and Methods
2.2.1 Bacterial strains, growth media, growth and expression conditions 
Bacterial strains used in this study are listed in Table 2.1. S. flexneri strains were 
routinely grown in tryptic soy broth (TSB). Pseudomonas aeruginosa, P. syringae, S. 
typhimurium, and E. coli were routinely grown in Luria-Bertani (LB) medium. Vibrio 
cholerae was routinely grown in Lenox broth. For microscopy studies all strains were 
grown overnight from a single colony in rich media and back-diluted 1:50 the following 
day into M9 minimal media supplemented with 0.2% (w/v) casamino acids, 0.2% (v/v) 
glycerol, 0.5 mg mL'* thiamine, 0.5 mg mL'^ tryptophan, 0.5 mg mL'* nicotinic acid, 0.1
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Table 2.1 - Bacterial Strains
Strain Relevant Genotype Source
E, coli
DHIOB K-12 cloning strain Invitrogen
DH5a K-12 cloning strain Invitrogen
MBG263 MCI 061 ^ompT:■Km^ Goldberg & Theriot, 
1995
MC1061 V  araD l39 A(ara-leu)7696 
galE lS galK16 A(lac) X74 
rpsL (Str^) HsdR2 (rk- 
mk+)mcrA mcrBl
Meissner er a/,1987
P. aeruginosa
PAK Wild-type L n e t al, 1997
PAK IspilA Axcp all PAK ApilA AxcpR Lu et al, 1997
PAK EpscC PAK ApscC Wolfgang et al, 2003
PAK tsvfr PAK Avfr Wolfgang et al, 2003
PAK ùçfteQ PAK AfleQ Arora et al, 1997
P. syringae
B728A Wild-type Willis g /a /, 1991
S. typhimurium
14028s Wild-type American Type 
Culture Collection
S. flexneri
2457T Wild-type serotype 2a Labrec et al, 1964
MBG283 2457T icsA::W Spec^ Steinhauer et a/, 1999
V. cholerae
0395 Classical Ogawa wild-type 
Sm'^
Mekalanos et al, 1983
KKV46 0395 AflrAlv.Cm^ MacZ K losee/a/, 1998
17
mM CaCh, and 0.5 mM MgS0 4 . Antibiotic concentrations used were as follows: 
ampicillin, 100 mg m L''; carbenicillin, 150 mg m L''; spectinomycin, 100 mg m L''; 
streptomycin, 100 mg m L''; and tetracycline, 100 mg m L'' for P. aeruginosa and 12.5 
mg m L'' for strains other than P. aeruginosa.
P. aeruginosa, V. cholerae, S. typhimurium, and E. coli cultures were grown at 
37°C to ODeoo 0.3-0.5 and then shifted to 25°C. At OD^oo 0.6 expression of icsAr.gfp 
was induced at 25°C for Ih by the addition o f either 0.2% (w/v) L-arabinose or 500 mM 
IPTG (final concentration), as appropriate. P. syringae cultures were grown at 25°C 
throughout and expression was induced for Ih by the addition o f either 2% (w/v) L- 
arabinose or 500 mM IPTG (final concentration), as appropriate.
2.2.2 Plasmid constructions and conjugation 
Plasmids used in this study are listed in Table 2.2.
2.2.2.1 Construction o f  pEHKOl, full-length IcsA, L-arabinose inducible promoter 
To construct pEHKOl, full-length icsA was cloned into a broad host-range vector, 
pJNlOS downstream of an L-arabinose inducible promoter to be introduced into P. 
aeruginosa (PAK) as follows. A non-methylated pMGB270 was digested with AccIII 
and one of the resulting fragments contained full-length icsA. The AccIII icsA fragment 
was ligated to a linearized Jfiwa/pJN 105 fragment, thereby creating pEHKOl.
2.2.2.2 Construction o f  pEHKIO, pJNI05 with Xbal and Pvul sites removed 
To construct pEHKlO, a Pvul and X bal site were removed by linearizing pJN105 
with X bal and Pvul and ligating to an annealed sequence, used with oligonucleotides 28 
and 29 (Table 3). These two sequences were annealed in a thermocycler with the
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Table 2.2 - Plasmids
Plasmid Relevant Genotype Referenee/Souree
pACYC184 E. coli plasmid cloning vector Tet"^ Chang & Cohen
pB AD24-/C&4 idi-m'-'-gfp flQAT>2A-VBAD-icsA507-620:'-gfp Amp*^ Charles et a l, 
2 0 0 1
pB AD24-/c5̂ 4507-729 : :g/̂ J pBAD24-PgxD-/c.5^6 5 0 7 -7 2 9 :Amp"^ Charles et a l, 
2 0 0 1
pEHKOl pJN105-Pfi.4D-/c5y4 Gm"^ This work
pEHKlO pJNlOS, Pvul and Xbal sites 
removed, Nhel introduced Gm*̂
This work
pEH K ll p EHK10-Pbad-/c5X Gm"^ This work
pEHK13 pEHK10-Pbad-/c.sz( Mutated Shine- 
Dalgarno and abolished false start 
codon Gm*̂
This work
pEHK18 pMMB67EH-Ptoc-/c5^A507-729::g^
Tet*̂
This work
pEHK20 pMMB67EH-P,ac-/c5y4507.62o::g/ï? Tet"^ This work
pJEH3 pMMB67EH-PMc-/c&4 507-620: -.gfp
Amp*^
This work
pJEH7 pMMB67EH-P,ac-fc.9/1 ̂ 507-729:
Amp"^
This work
pJNlOS Broad host range vector, Gm"^ Newman et al, 
1999
pMBG270 pBR322-/cj'y4 Magdalena & 
Goldberg 2002
pMMB67EH Broad-host-range vector, Amp*^ Fursteeta/., 1986
pRK2013 Helper plasmid for conjugal transfer, 
Kan*^
Fursteeta/., 1986
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following cycles; 95°C for 2 minutes, a decreasing ramp temperature from 95°C to 25°C 
for 45 minutes. When this sequence was ligated to a linearized pJNlOS, the Pvul and 
X bal sites were abolished and an Nhel site was introduced, thereby creating pEHKlO.
2.2.2.3 Construction o f  pEH Kl 1, full-length icsA inpEHKlO  
To construct pE H K ll, full-length icsA was cloned into pEHKlO as follows. 
pMBG270 was digested with A cclll and one of the resulting fragments contained full- 
length icsA. The A cclll icsA insert was ligated to a linearized Xm al pEHKlO fragment, 
thereby creating pEH K ll.
2.2.2.4 Construction o f  pEHKl 3, full-length IcsA, L-arabinose inducible promoter 
A 114 bp megaprimer was amplified from pEHKOl with oligonucleotides 23 and 
24 (Table 2.3) to create a mutated Shine-Dalgarno sequence o f IcsA (Table 2.4). This 
megaprimer was used along with oligonucleotide 25 (Table 2.3) to amplify a fragment 
including; part of IcsA, the mutated Shine-Dalgamo, and mutated false start codon from 
pEHKOl, thereby creating a 394 bp fragment. The 394 bp fragment was digested with 
EcoRI and X bal and ligated to pEHKl 1 digested with Xbal and EcoRI thereby removing 
the old Shine-Dalgamo sequence and thus creating pEHK13.
2.2.2.5 Construction o f  pJEH3 
To construct pJEH3 for expression of ICSA507-6 2 0-GFP in P. aeruginosa, the 
coding sequence for ICSA507-6 2 0-GFP was cloned into pMMB67EH downstream of its 
IPTG-inducible promoter using the following strategy. pBAD24-/c5y4507-62o::g^ was cut 
with Nhel and the resulting 3’-overhangs were filled in with T4 DNA polymerase. The 
resulting blunt-ended linear vector was then cut with Hindill, liberating the coding
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Table 2.3: Oligonucleotides
Oligo 23 GGGCTAGCGAATTCCTGCAG
CGC
Megaprimer o f mutated Shine- 
Dalgarno sequence off pEHKOl, 
Forward
Oligo 24 GGGTCATATTACAAAAAAAT
TTGTGAATTTGATTCATGGA
CTATTCCTCC
Megaprimer o f mutated Shine- 
Dalgarno sequence off pEHKOl, 
Reverse
Oligo 25 GCTTAGTTCTAGATGCATGA
GAGGGG
Used with megaprimer to amplify 
part o f icsA, the mutated Shine- 
Dalgamo, and mutated false start 
codon off pEHKOl
Oligo 28 CTAGTGGGATAGCCCCTAGC
TAGCATCGTAACGGTAGGAA
GCCAT
Annealed with Oligo 29 to remove 
Xbal and Pvul sites off pJN 105
Oligo 29 GCCTTCCTACCGTTACGATG
CTAGCTAGGGGCTATCCCA
* Bold, Nhel restriction site was 
introduced
Annealed with Oligo 28 to remove 
Xbal and Pvul sites off pJN 105
Oligo 30 CGAATCCGATCGGGCTGCTG
GAGATGGCGG
Amplify tet off pACYC184, 
Forward
Oligo 31 ATCGAATCCGATCGGCACCT
GAAGTCAGCCCC
Amplify tet off pACYC184, 
Reverse
2 1
Table 2.4 - Shine-Dalgarno (S-D) sequence of icsA
Original S-D sequence ACTGATAATATAG TGCATG
Mutated S-D sequence ACTGGAGGAATAG TÇCATG
The icsA Shine-Dalgarno sequence found in Shigella appeared weak. 
For icsA to be expressed in Pseudomonas, the Shine-Dalgarno was 
strengthened by mutating the A-T rich sequence to become G-C rich. 
Additionally, there appeared to be a false start codon upstream of the 
translational start site. Consequently, the codon was mutated from G to 
C to avoid premature translation.
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sequence for ICSA507-620-GFP. This DNA fragment was ligated into pMMB67EH, which 
had been linearized with Smal and Hindill, thereby creating plasmid pJEH3.
2.2.2.6 Construction o f  pJEH7 
In a similar manner, pJEH7, which contains the sequence coding for IcsAd507-729- 
GFP, was constructed by ligating a BamHl-Pstl fragment that was derived from 
pBAD24-/c5^D507-729::g^ and that contains the coding sequence for IcsAd507-729-GFP into 
pMMB67EH. Tetracycline-resistant derivatives of pJEH3 and pJEH7, pEHK20 and 
pEHKlS, were generated by introducing a tetracycline resistance gene into the unique 
Pvul site located in the bla gene of pJEH3 and pJEH7. In both pEHKlS and pEHK20, 
the introduced tetracycline resistance gene was orientated in the same direction as the 
interrupted bla gene.
2.2.2.7 Construction o f  pEHKlS and pEHK20 
To construct pEHKlS and pEHK20 for expression of ICSA507-6 2 0-GFP in PAK  
Avfr and PAK AfleQ, the sequence coding for ICSA507-6 20-GFP was cloned into a broad 
host-range vector pMMB67EH downstream of its IPTG-inducible promoter as follows. 
pJEH3 was introduced into DM1, a dam' E. coli strain. The non-methylated pJEH3 was 
linearized with Pvul and ligated to a Tetracycline gene, which was amplified from 
pACYC184 with oligonucleotides 30 and 31 (Table 2.3), thereby creating pEHK20. In a 
similar manner, pEHK18, which contains the sequence coding for IcsAa50 7-729-GFP, was 
constructed by ligating a Pvul fragment containing the tetracycline gene that was derived 
from pACYC184 into pJEH7. Both pEHK18 and pEHK20 were transferred from the E. 
coli cloning strain DHIOB to the appropriate P. aeruginosa strain by conjugation using 
the helper plasmid pRK2013.
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2.2.3 Expression o f  icsA::gfp (pJEH3, pJEH7, pEH K lS andpEHK20),
western blot analysis
To determine whether icsA::gfp is expressed from pJEH3, pJEH7, pEHKlS and 
pEHK20 in P. aeruginosa, V. cholerae, S. typhimurium, and E. coli, cultures were grown 
overnight at 37°C. The following day, cultures were back-diluted ( 1  ;50) to ODeoo 0.3-0.5 
and then shifted to 25°C. At ODaoo 0.6 expression of icsA::gfp was induced at 25°C for 
one hour by the addition of either 0.2% (w/v) L-arabinose or 500 mM IPTG (final 
concentration), as appropriate. P. syringae cultures were grown at 25°C throughout and 
expression was induced for 1 hour by the addition of either 2% (w/v) L-arabinose or 500 
mM IPTG (final concentration), as appropriate.
Whole cell proteins were prepared from this culture by harvesting equivalent 
number o f cells and hence protein. Samples were then centrifuged at 12,800 x g  at 4°C 
for two minutes. The pellets were resuspended in 0.2 M Tris (pH 8.0) at 4°C in half of the 
original harvested volume. The samples were then centrifuged at 12,800 x g at 4°C for 
two minutes. The supernatants were discarded and the pellets were resuspended in 200 
[xl 10 mM Tris (pH 7.4) plus 50 |xl 4X SDS-PAGE loading buffer containing p- 
mercaptoethanol.
The whole cell protein preparations were loaded onto a 12.5% (v/v) SDS- 
polyacrylamide gel and separated by electrophoresis at 30 mA. Proteins were then 
transferred to polyvinylidene fluoride (PVDF) membrane for two hours at 150 mA. 
PVDF membranes were blocked with IX PBS containing 5% (w/v) dried non-fat 
powdered milk (PBS/5% (w/v) milk) overnight at 4°C. The following day, the PVDF 
membrane was probed with a rabbit GFP polyclonal antibody (1:5000) for two hours at
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37°C. Then it was washed with PBS/5% (w/v) milk and PBS/Tween-20 for 15 minutes. 
Finally, the membrane was incubated with the secondary antibody, anti-rabbit IgG, 
horseradish peroxidase linked F(ab’)̂  fragment from donkey (1:10,000) for one hour at 
25°C. GFP was detected by ECL kit (Amersham) according to the manufacturer’s 
instructions and visualized on a Typhoon scanner using ImageQuant Software.
2.2.4 Expression o f  IcsA, (pEHKOl and pEHKl 3), western blot analysis
To determine whether full-length IcsA is expressed from pEHKOl, pEHKOl was 
induced in three E. coli backgrounds, DHIOB (wild-type), M CI061 (wild-type) and 
MBG263 (M CI061 EompT); and in two Pseudomonas backgrounds, PAK (wild-type) 
and B728A (wild-type). DHIOB pEHKOl or pEHK13 was grown overnight in LB 
medium supplemented with 0.02% (w/v) glucose and gentamycin, 100 ^g m L''. The 
following day the culture was back-diluted (1:50) in LB medium containing gentamycin, 
100 |xg m L''. Upon reaching an ODôoo 0.4-1.0, pEHKOl was induced with 0.2% (w/v) l-  
arabinose for one hour at 37°C.
Whole cell proteins were prepared as previously described in section 2.2.3. The 
whole cell protein preparations were loaded into a 12.5% (v/v) SDS-polyacrylamide gel 
and separated at 30 mA. Proteins were then transferred to polyvinylidene fluoride 
(PVDF) membrane for two hours at 150 mA. PVDF membranes were incubated with 
PBS/5% (w/v) milk overnight at 4°C. The following day, the PVDF membrane was 
probed with a rabbit IcsA polyclonal antibody (1:10,000) for two hours at 37°C. Then it 
was washed with PBS/5% (w/v) milk and PBS/Tween-20 for 15 minutes. Finally, the 
membrane was incubated with the secondary antibody, anti-rabbit IgG, horseradish 
peroxidase linked F(ab’)̂  fragment from donkey (1:10,000) for one hour at 25°C. IcsA
25
was detected by ECL kit (Amersham) according to the manufacturer’s instructions and 
visualized on a Typhoon scanner using ImageQuant Software.
2.2.5 Indirect immunofluorescence o f  IcsA in S. flexneri
For indirect immunofluorescence, 2457T was grown overnight in minimal 
medium at 37°C. The following day, cultures were back-diluted (1:100) and grown to an 
ODeoo 0.4-0.6. Cells were centrifuged onto coverslips at 700 x g  for ten minutes and 
fixed with 3.7% (v/v) paraformaldehyde in PBS for 20 minutes at 25°C. After fixation, 
cells were labeled with IcsA antiserum (1:200). Subsequently, cells were incubated with 
the secondary antibody, goat anti-rabbit rhodamine-conjugated IgG (1:1000) in the dark 
for 20 minutes at 25°C. Cells were mounted onto a glass and observed immediately. 
Fluorescence and phase microscopy were performed by using an Olympus BX51 
microscope with Olympus filters. Images were captured digitally by using an Olympus 
U-CMAD3 camera and PictureFrame 2.3 Software. The eolor figure was assembled by 
capturing in the rhodamine wavelength.
2.2.6 Indirect immunofluorescence o f  IcsA in P. syringae
For indirect immunofluorescence, B728A pEHK13 was grown overnight in 
minimal medium at 25°C. The following day, cultures were back-diluted (1:100) and 
grown to an ODeoo 0.4-0.6 and induced with 2% (w/v) L-arabinose for two hours at 25°C. 
Cells were centrifuged onto coverslips at 700 x g  for ten minutes and fixed with 3.7% 
(v/v) paraformaldehyde in PBS for 20 minutes at 25°C. After fixation, cells were labeled 
with IcsA antiserum (1:200). Subsequently, cells were incubated with the secondary 
antibody, goat anti-rabbit rhodamine-conjugated IgG (1:1000) in the dark for 20 minutes
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at 25°C. Cells were mounted onto a glass slide and visualized as described in section 
2.2.5.
2.2.7 Microscopy and tabulation o f  localization patterns 
Tabulation o f the localization pattern of each construct was performed in each of 
3-5 independent experiments on approximately 120 randomly selected cells for each 
strain. Cells were mounted onto a glass slide and visualized as described in section 2.2.5. 
Each cell was categorized as polar, non-polar or diffuse based on the distribution and 
location o f the GFP in the bacterial cell.
2.2.8 Media
Liquid and solid media were prepared by dissolving the specified quantities of 
reagents in distilled water.
2.2.8.1 Tryptic Soy Broth Medium (TSB) (per liter): 30g tryptic soy broth, 15g
Bacto agar, for Shigella growth, TSB contains 0.1 g Congo Red
2.2.8.2 Luria-Bertani Medium (LB) (per liter): lOg tryptone, 5g yeast extract, 
lOg NaCl, 15g Bacto Agar
2.2.8.S 10XM 9 Salts (per liter): 60g Na2HP0 4 , 30g K H 2PO 4, lOg N H 4C I, 5g
NaCl
2.2.8.4 M9 Medium (per liter): 100 ml lOX M9 salts, 1 ml 1 M MgS0 4 , 10 ml 10
mM CaCL, 10 ml 50% (v/v) glycerol, 100 pi 10 mg m f’ thiamine
2.3 Results and Discussion 
As previously reported, IcsAgQ̂  ẑo GFP localized to the pole in S. flexneri, E. coli, 
S. typhimurium and V. cholerae (Charles et a l ,  2001) (Figure 2.1 B and C, and Table 2. 
5). The percentage of cells containing fluorescent polar foci in V. cholerae, 0395, 
expressing pBAD24-/c.sA507.62o"g/^ was substantially lower than in each of the 
Enterobacteriaceae (Table 2.5 and Figure 2.1 C compared to B). The ICSA50 7-620-GFP
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fusion was stable in V. cholerae, but its level o f expression was 6- to 10-fold lower than 
for each of the Enterobacteriaceae, as determined by western blot analysis (data not 
shown -  HJW). For each enterobacterial strain and V. cholerae, the IcsA-GFP fusion that 
lacks the polar localization sequence, lcsA^go7 .7 2 9-GFP, displayed diffuse cytoplasmic 
fluorescence in essentially all cells examined, consistent with the localization of IcsAgo?- 
6 2 0 -GFP to the pole o f these organisms being a result o f a specific targeting mechanism. 
Whereas S. flexneri lacks flagella and Salmonella spp. and E. coli have peritrichous 
flagella, flagella expressed by V. cholerae are polar, therefore it was possible that the 
decreased frequency o f polar IcsA foci in V. cholerae might be a result o f interference of 
polar flagellar structures with the proper localization of IcsA. Such interference might 
occur if, for example, a polar flagellar protein were binding to the same polar protein or 
structure to which IcsA would normally bind. However, in a non-flagellated V. cholerae 
strain in which Fir A, a master regulator o f flagellar biosynthesis, was absent (Klose et al., 
1998), polar localization of IcsA was unaltered (strain KKV46, data not shown - HJW), 
indicating that the presence of flagellar structures dependent on FlrA was not responsible 
for the observed low efficiency of IcsA localization to the pole. Therefore, although we 
cannot eliminate the possibility that a flagellum-associated structure that is present in the 
non-flagellated FlrA' V. cholerae strain interferes with polar localization of IcsA, we 
believe that the low efficiency of polar localization of ICSA5 0 7 -6 2 0 -GFP in V. cholerae is 
more likely due to the relatively low level of expression of the fusion protein in this 
organism (data not shown -  JEH).
To explore whether the mechanism of targeting of IcsA was conserved among 
Pseudomonas species, we examined localization of ICSA507.6 2 0-GFP in P. aeruginosa and
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Figure 2.1: IcsA localizes to the pole of V. cholerae and Pseudomonas species.
(A) Distribution of IcsA on the surface o f intact S. flexneri 2457T cells. Left, indirect 
immunofluorescence using anti-IcsA antiserum. Right, phase image o f same microscopic 
field. (B through E) Localization o f ICSA50 7-6 20-GFP in S. flexneri icsA strain MBG283
(B), V. cholerae wild-type strain 0395 (C), P. aeruginosa wild-type strain PAK (D), and 
P. syringae wild-type strain B728A (E), by direct epifluorescence microscopy. Left 
panels, GFP. Right panels, phase image o f same microscopic field. Arrows, non-polar 
foci o f IcsA507-62 0-GFP in cells that also contain polar foci; arrowheads, non-polar foci in 
cells that lack polar foci. Images are representative o f those obtained in three or more 
independent experiments. Bar, 2 pm.
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Table 2.5: Distribution o f ICSA507-620-GFP in Enterobacteriaceae, F. cholerae, and
Organism Relevant Strain 
Background
Distribution of Fluorescent Signal 
(%, mean ± S.D.)
Polar
Foci*
Diffuse Non-polar
Foci
S. flexneri icsA- 97 ± 2 1 ± 2 <1
E. coli wild-type 94 ± 3 6 ± 3 <1
S. typhimurium wild-type 98 ± 2 2 ± 2 <1
V. cholerae wild-type 29 ± 14 70 ± 1 4 <1
P. aeruginosa wild-type 43 ±21 44 ± 2 6 1 4 ±5
* - cells displaying bipolar foci, unipolar foci in the presence o f additional foci, or 
bipolar foci in the presence of additional foci were all categorized as “polar” in this 
study. IcsA5 0 7 -6 2 o-GFP was expressed from either pQAUlA-icsAsm-ao'-'-gfp or pJEH3. 
All strains carrying either pBAD24-/c5'yl^507-729'.:g^ or pJEH7, which also expresses 
IcsA^5 0 7 -7 2 9 -GFP, displayed diffuse fluorescence in >99% of the cells examined (data 
not shown).
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p. syringae. In both wild-type P. aeruginosa (PAK) and wild-type P. syringae (B728A), 
IcsA5 0 7 -6 2 o-GFP localized to the cell poles. In P. aeruginosa cells and P. syringae cells, 
discrete polar fluorescent foci, which were similar in morphology and pattern to those 
seen in the Enterobacteriaceae and V. cholerae (Figure 2.1 D and E; Table 2.5 and 2.6), 
were observed. However, a second localization phenomenon was seen in both P. 
aeruginosa and P. syringae, yet was rarely observed (s  1%) in either the 
Enterobacteriaceae tested or in V. cholerae. In Pseudomonas cells, non-polar fluorescent 
foci were observed at one or more locations within the bacteria (Table 5 & 6, “Non-polar 
Foci”), in either the presence or absence of polar foci (Figure 2.1 D and E, arrow or 
arrowhead, respectively). The non-polar foci observed in the Pseudomonas strains were 
unlikely to be the result of over-expression of ICSA5 0 7 -6 2 0 -GFP, as western blot analysis 
showed that the level of expression of ICSA5 0 7 .6 2 0 -GFP was modestly (2- to 4-fold) lower 
in Pseudomonas strains than in the Enterobacteriaceae tested. Furthermore, non-polar 
foci were not observed in cells that expressed IcsA^^o  ̂^zg-GFP. Taken together, these data 
suggest that the mechanism of polar localization is conserved in Pseudomonas species 
because a sub-population of cells displays polar foci. The presence of both non-polar and 
polar foci in Pseudomonas species, but only polar foci in Enterobacteriaceae and V. 
cholerae raise the possibility that polar proteins present in the Pseudomonas species 
tested may compete with localization of IcsA to the pole, resulting in the localization of 
some IcsA to non-polar sites in the cytoplasm. Alternatively, these findings might reflect 
an alteration o f IcsA recognition of the polar localization machinery in the Pseudomonads 
that may have occurred as a result of evolutionary divergence of these organisms.
To explore whether the presence o f non-polar ICSA507.620GFP foci in P. aeruginosa
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Table 2.6 - Distribution of IcsAgoy-eao-GFP 'm Pseudomonas species.
Organism Relevant Strain 
Background
Distribution of Fluorescent Signal 
(%, mean ± S.D.)
Polar Foci* Diffuse Non-polar
Foci
P. aeruginosa wild-type 40 ± 5 46 ± 4 1 3 ± 3
vfr- 40 ± 4 44 ± 2 1 6 ± 4
fleQ- 65 ± 3 32 ± 4 3 ±  1
P. syringae wild-type 29 ± 5 56 ± 3 1 5 ± 5
* Cells displaying bipolar foci, unipolar foci in the presence of additional foci, or 
bipolar foci in the presence o f additional foci were all categorized as “polar” in this 
study. IcsA5 0 7-6 2o-GFP was expressed from pEHK20. All strains carrying pEHKlS, 
which expresses IcsA dso7-729-GFP, displayed diffuse fluorescence in >99% of the cells 
examined (data not shown). The distribution of fluorescent signals observed in the P. 
aeruginosa fleQ  mutant differed signiflcantly from that seen in the wild type {P < 0.01). 
There was no significant difference between the vfr mutant and wild type P. aeruginosa 
(P > 0.4).
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might result from interference of certain discrete cellular structures with IcsA, we next 
examined whether either of two known polar structures o f P. aeruginosa, the polar 
flagellum or the polar type IV pilus, might interfere with the polar localization o f IcsAso?. 
6 2 0-GFP in P. aeruginosa (Lory 1998). To address this, two mutant strains, a P. 
aeruginosa strain that lacks fleQ , the major flagellar transcriptional regulator, which 
controls the expression of the entire polar flagellum proteins and is unable to synthesize 
polar flagella (Dasgupta et a l,  2000), and a P. aeruginosa strain that lacks vfr, the major 
virulence factor regulator, which controls the expression of many virulence proteins and 
specifically is unable to synthesize the polar type IV pili biogenesis machinery, were used 
(Frost et a l ,  1977) (Beatson et a l ,  2002). We hypothesized that if  interference between 
our targeting construct and polar proteins in P. aeruginosa were occurring, then in the 
absence of these global regulators o f polar proteins, we would detect an increase in polar 
foci. However, our results showed that the pattern of localization o f ICSA507-6 2 0-GFP in 
the vfr mutant was indistinguishable from that of the wild-type strain, with both polar and 
non-polar foci observed at frequencies that were comparable to those observed for the 
wild type (Figure 2.2 C compared to 2.2 A; Table 2.6). In contrast, in the fleQ  mutant, 
an altered pattern of localization of ICSA5 0 7-6 20-GFP was observed (Figure 2.2 E, Table 
2.6). The number o f polar foci observed in this strain background was significantly 
higher than that observed in wild-type PAK {P < 0.01, two tailed t-test. Table 2.6; Figure
2.2 E and 2.2 A) and was concomitant with a significant decrease compared to the wild- 
type strain in the number of cells displaying diffuse signals (P < 0 .01 , two tailed t-test. 
Table 2.6) and non-polar foci (P < 0.01, two tailed t-test. Table 2.6). As in the wild-type 
strain (Figure 2.2 B), the localization-deficient derivative o f IcsA, IcsA^^Q .̂Tzg-GFP,
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Figure 2.2: Enhanced polar localization of IcsA in P. aeruginosa in the absence of 
the polar protein FleQ.
Localization o f ICSA507-620-GFP (A, C, E) or o f IcsA d507-729-GFP (B, D, F ) in wild-type P. 
aeruginosa (strain P A K ) (A, B), an isogenic vfr mutant (C, D), and an isogenic f le Q  
mutant (E, F), by direct epifluorescence microscopy. Left panels, G F P . Right panels, 
phase image of same microscopic field. Images are representative of those obtained in 
three or more independent experiments. Bar, 2 pm.
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displayed diffuse fluorescence in both the fleQ  and the vfr mutant.
Taken together, these data are consistent with competition for the polar targeting 
machinery between FleQ-dependent proteins and IcsAjqv^jo-GFP. Competition between 
FleQ-dependent proteins and IcsA would imply that P. aeruginosa and Shigella spp. have 
evolved the capability for discrete polar proteins to utilize the same polar targeting 
machinery. Moreover, the ability of discrete proteins to use the same polar targeting 
machinery implies that the targeting machinery is likely to be highly conserved. 
However, we cannot eliminate the possibility that a FleQ-dependent protein directly or 
indirectly interacts with the IcsA-GFP fusion protein, thereby altering its interaction with 
the targeting apparatus. It also remains unclear whether pili synthesis is occurring in P. 
aeruginosa cells, which may account for the similar number of polar foci in both wild- 
type and vfr mutant cells.
We observed that the frequency o f polar foci was significantly lower in 
Pseudomonas than in the Shigella, Escherichia, and Salmonella strains. Therefore, it is 
possible that some unidentified polar proteins in Pseudomonas interfere or compete for 
the targeting mechanism used by ICSA507-620-GFP. Since it was unclear which 
Pseudomonas proteins were responsible for interference, we decided to conduct 
interference assays in which full-length IcsA and ICSA507-620-GFP would be expressed 
simultaneously in the same cells to determine whether full-length IcsA interfered with the 
targeting o f ICSA507-620-GFP to the bacterial pole in Pseudomonas. We went to great 
lengths to express icsA in P. aeruginosa, but were never able to stably express full-length 
icsA in a P. aeruginosa background. Consequently, interference assays were never 
conducted. Our attempts to express IcsA in Pseudomonas are described below.
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To determine whether the pJN105 derivative carrying icsA, pEHKOl expressed 
IcsA, a -125 kDa protein, pEHKOl was induced with 0.2% (w/v) L-arabinose for one 
hour at 37°C in DHIOB (K-12 wild-type). It was determined that IcsA was expressed 
from this plasmid and resulted in a -95 kDa band, as judged by western blot analysis 
(Figure 2.3). A -95  kDa resulted because OmpT, an outer membrane protease found in 
E. coli is able to cleave IcsA. Therefore, pEHKOl was then introduced into a different E. 
coli background that lacked ompT, an outer membrane protease that is capable of 
cleaving IcsA. IcsA was expressed in M CI061 and MBG263 (MC1061-Aomp7) which 
resulted in a -95 kDa band and -125 kDa band, respectively, as judged by western blot 
analysis (Figure 2.4).
Subsequently, icsA from pEHKOl was expressed in a P. aeruginosa, PAK and 
induced with 2% L-arabinose for one hour at 37°C. However, IcsA could not be detected 
in PAK, as judged by western blot analysis (Figure 2.5). Therefore, the Shine-Dalgarno 
(S-D) sequence o f icsA was examined and was found to be weak. As a result, the S-D 
sequence of icsA was improved from being AT A AT to GAGGA (Table 2.4). 
Furthermore, upon close inspection, there appeared to be an alternative translational start 
that if used would result in translation o f the wrong frame. Therefore, this sequence GTG 
was changed to GTC (Table 2.4). The resulting plasmid, pEHK13, containing full-length 
icsA with a strengthened S-D sequence and an obliterated false start codon was 
introduced in an E. coli background, DHIOB. IcsA was expressed from pEHK13 in 
DHIOB and as a result of these changes, levels of IcsA expression were significantly 
higher that those observed previously (Figure 2.6).
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Figure 2.3: IcsA is expressed from pEHKOI in E. coli
pEHKOl (pJN105-/c5^) and pJNlOS (empty vector) was induced for one hour at 37°C 
with 0.2% (w/v) L-arabinose in an E. coli background, DHIOB. Samples were 
normalized to total protein, separated by SDS-PAGE, and transferred to a PVDF 
membrane. IcsA was detected by immunoblotting with an anti-IcsA antibody, induced 
with 0.2% (w/v) L-arabinose, one hour at 37°C. NI, not induced. A -95  kDa band is 
seen because of the presence of OmpT in E. coli, which is able to cleave -125 kDa IcsA.
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Figure 2.4: IcsA is expressed from pEHKOl in two E. coli strains, MBG263 and 
MC1061.
pEHKOl (pJNlGS-toy^) was induced for one hour at 37°C with 0.2% (w/v) L-arabinose 
in M CI061 and MBG263 (MC1061-Aomp7). Samples were normalized to total protein, 
separated by SDS-PAGE, and transferred to a PVDF membrane. IcsA was detected by 
immunoblotting with an anti-IcsA antibody. OmpT cleaves IcsA and results in a ~95 
kDa band.
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Figure 2.5: PAK does not express IcsA from pEHKOl
Samples were normalized to total protein, separated by SDS-PAGE, and transferred to a 
PVDF membrane. IcsA was detected by immunoblotting with an anti-IcsA antibody, 
induced with 0.2% (w/v) L-arabinose, one hour at 37°C. NI, not induced. IcsA cannot 
be detected in PAK.
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Figure 2.6: DHIOB expresses IcsA from pEHKOl and pEHK13. PAK does not 
express IcsA from pEHK13
Samples were normalized to total protein, separated by SDS-PAGE, and transferred to a 
PVDF membrane. IcsA was detected by immunoblotting with an anti-lcsA antibody. IN, 
induced with 0.2% (w/v) L-arabinose in E. coli strains and 2% (w/v) L-arabinose in PAK, 
one hour at 37°C. NI, not induced. PAK does not express IcsA from pEHK13.
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Next, to determine whether IcsA could be expressed in P. aeruginosa, pEHK13 
was introduced into PAK and induced with different concentrations o f L-arabinose for 
one hour at 37°C (Figure 2.7). However, IcsA, expressed from pEHK13 could not be 
detected in P. aeruginosa (Figure 2.7).
Because IcsA could not be detected in P. aeruginosa, we attempted to express this 
construct in another Pseudomonas species, P. syringae, B728A. pEHKOl and pEHK13 
were both introduced into B728A and induced with L-arabinose at 25°C for one hour. 
IcsA was expressed in B728A from pEHK13 and not from pEHKOl (Figure 2.8).
We next needed to determine whether IcsA was localized to the bacterial pole on 
the surface of P. syringae. Surface labeling of IcsA in B728A, using indirect 
immunofluorescence was done in order to conduct the interference assays. However, 
from indirect immunofluorescence, IcsA was not found to be polar (Figure 2.9). 
Consequently, interference assays with P. syringae were not conducted.
2.4 Conclusion
In summary, our data indicate that the positional information specifying polar 
localization of Shigella IcsA is conserved in P. aeruginosa and P. syringae because in 
each of the strains examined, a sub-population of cells contained polar foci. Moreover, 
the data are consistent with interference by FleQ-dependent proteins in P. aeruginosa 
with polar localization of IcsA, suggesting that FleQ-dependent proteins and IcsA may 
use the same molecular machinery to localize to the cell pole. Based on these and earlier 
results, it seems possible that positional machinery recognized by at least some polar 
proteins may be conserved widely among y-proteobacteria. The extent of conservation of
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PAK pEHK13
Figure 2.7: PAK does not express IcsA from pEHK13
Samples were normalized to total protein, separated by SDS-PAGE, and transferred to a 
PVDF membrane. IcsA was detected by immunoblotting with an anti-IcsA antibody. IN, 
induced with different concentrations of L-arabinose, 1 hour at 37°C. NI, not induced. 
IcsA, expressed in pEHK13 can be detected in E. coli, but not in Pseudomonas 
aeruginosa.
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Figure 2.8: B728A expresses IcsA from pEHK13
Samples were normalized to total protein, separated by SDS-PAGE, and transferred to a 
PVDF membrane. IcsA was detected by immunoblotting with an anti-IcsA antibody. IN, 
induced with 0.2% (w/v) L-arabinose, 1 hour at 37°C in E. coli strains. IN, induced with 
2% (w/v) L-arabinose, one hour at 25°C in P. syringae (B728A). NI, not induced. IcsA, 
expressed from pEHKOl cannot be detected in B728A. However, IcsA, expressed from 
pEHK13, can be detected in B728A.
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Figure 2.9: IcsA is distributed all over the bacterial surface in P. syringae.
Secretion of IcsA in a P. syringae (B728A) background. IcsA detected on the surface of 
intact bacteria that carry pEHK13. Indirect immunofluorescence (right panel) and phase 
(left panel).
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this positional machinery suggests that it is utilized widely for the proper positioning of 
proteins in many y-proteobacterial genera and/or that it is required for fundamental 
cellular processes (Shapiro et al., 2002; Janakiraman et al., 2004).
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CHAPTER 3
CHARACTERIZATION OF THE OMPTIN FAMILY AND THE ROLES AND 
REGULATION OF THE OUTER MEMBRANE PROTEASE,
ICSP IN SHIGELLA FLEXNERI 
3.1 Introduction
IcsP, an outer membrane protease, belongs to the omptin family of proteins, 
which are highly homologous. These omptins have been identified in several gram- 
negative bacteria that are pathogenic to humans (Table 3.1). Omptin-expressing bacterial 
species cause a variety of infectious diseases ranging from highly fatal plague to 
beneficial commensalism. The omptin family includes OmpT and OmpP of E. coli, PgtE 
of Salmonella typhimurium, Pla o f Yersinia pestis and IcsP of Shigella flexneri. Omptin 
proteases are highly related in structure and share approximately 50% sequence identity, 
have major forms of 290-301 amino acids and lack or have a low cysteine content (Table 
1) (Kukkonen et a i, 2004).
3.1.1 Structure o f  OmpT 
The structure of omptin proteins can be predicted from the best-characterized 
member o f the omptin family, OmpT of E. coli. The crystal structure o f OmpT reveals a 
vase-shaped (3-barreI with 1 0  antiparallel p-strands connected by four short periplasmic 
turns, o f unknown function and five extracellular loops (Cowan et a l ,  1992; Vandeputte-
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Table 3.1: The Omptin Family of Proteases
Bacterium Om ptin Identity to 
Om pT (%)
Identity to 
IcsP (% )
Escherichia coli OmpT 100 58
Salmonella typhimurium PgtE 50 39
Shigella flexneri IcsP 60 100
Yersinia pestis Pla 47 41
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Figure 3.1: Overall structure of Om pT (Vandeputte-Rutten et al., 2001)
(A) Ribbon representation of OmpT. The extracellular space is at the top of the figure 
and the periplasm is at the bottom. The extracellular loops are labeled LI through L5. 
Aromatic residues that are located at the boundary of the hydrophobic and hydrophilic 
area on the molecular surface are colored yellow. The proposed catalytic residues are 
depicted in red and the purple colored areas are the putative LPS-binding sites. (B) 
Stereo representation o f a modeled LPS molecule at the putative binding site. The 
orientation o f the OmpT molecule is rotated 90° along the barrel axis, with respect to (A). 
This figure was prepared by (Vandeputte-Rutten et a l, 2001).
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Rutten et a i ,  2001) (Figure 3.1). The extracellular loops are predicted to be responsible 
for the protein’s activity and specificity (Kukkonen et al., 2001). The barrel extends 
approximately 40 Â from the lipid bilayer with the outermost mobile loops, surrounding 
the active site, located just above the edge of the lipopolysaccharide core region. A 
hydrophobic band is located in the outer membrane, and like other trans membrane 
proteins, OmpT has two rings o f aromatic residues at the water-lipid interface. Within 
the membrane region, the barrel is hollow and carries an internal positive charge.
3.1.2 Proteolytic characteristics o f  OmpT 
OmpT cleaves its substrates between two consecutive basic residues. A 
consensus sequence, (Arg/Lys) (ArgZLys)-Ala has been identified (Dekker et al., 2001). 
The active site of OmpT is located at the top of the protein placing it on the bacterial 
surface. It is located within a deep negatively charged groove, formed by loops L4 and 
L5 on one side and LI, L2, and L3 on the other side (Figure 3.1 B) (Vandeputte-Rutten et 
a l,  2001). The catalytic residues in this proposed active site are conserved among all 
members o f the omptin family and are comprised of four residues; 3 Asp and 1 His 
(Hritonenko et a l ,  2007). It has been proposed that a water molecule positioned between 
Asp83 and His212 is activated by the His212-Asp210 dyad and subsequently performs 
the nucleophilic attack on the scissile peptide bond (Vandeputte-Rutten et a l ,  2001). 
Sequence alignment analysis of omptin proteases shows that the catalytic amino acids are 
completely conserved among the omptins (Table 3.2). Furthermore, it has been shown 
that amino acid residues vary in the surface loops surrounding the active site (Table 3.2). 
It has been speculated that minor sequence variations in the surface loops o f OmpT may 
have profound effects on the target specificities of the individual omptins. In this regard
50
Table 3.2: Amino acids among the omptin proteins
OmpT IcsP Pla PgtE
Catalytic amino acids
Asp83 + + + +
Asp 85 + + + +
Asp 210 + + + +
His 212 + + + +
Surface loop amino acids
Glu 27 + + + +
Ser 40 + + + +
Leu 42 + + + +
Met 81 + + + +
Asp 97 + + + +
Ser 99 + + + +
His 101 + + + +
Ala 143 + + + +
Tyr 150 + + + +
lie 170 + + + +
Asp 208 + + + +
Ser 223 + Asp Glu Glu
Thr263 + + + +
Ala 280 + + + +
He 282 + + + +
LPS binding region
Tyr 134 + + + +
Glu 136 + + + +
Arg 138 + H- + +
Arg 175 + Leu + +
Lys 226 + + Ser Glu
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most studies have focused on the omptin protease, OmpT of E. coli. Previous work has 
shown that a change of the amino acid from Ser to Arg at position 223 within the surface 
loops o f OmpT, significantly alters its cleavage specificity from Arg-Arg to Ala-Arg 
(Varadarajan et a/., 2005). As yet, it remains unclear whether subtle amino acid 
differences within the extracellular loops of the other omptins confer different cleavage 
specificities.
3.1.3 Omptins functions are dependent on LPS
LPS, a molecule present in the outer leaflet of the gram-negative envelope, affects 
the assembly and proper folding o f several outer membrane proteins, including the 
omptins (Kramer et al., 2000; Kramer et al., 2002). Previous work has shown that OmpT 
displays enzymatic activity only in the presence of lipopolysaccharide (LPS) (Kramer et 
al., 2000). Kramer et al. (2002) hypothesized that LPS induces a subtle conformational 
change in the omptin protein that is required for native active site geometry. However, it 
is still not entirely clear how LPS contributes to OmpT stability and activity. Ferguson et 
al. (1998) identified a structural motif for LPS binding consisting o f four basic amino 
acids in the crystal structure FhuA-LPS. A structure-based search in the Protein Data 
Bank revealed that a subset of four amino acids involved in the FhuA-LPS interactions is 
conserved in several LPS-binding prokaryotic proteins (Ferguson et a l ,  2000). When 
OmpT is compared to FhuA-LPS complex, three of the four residues (shown in blue in 
Figure 3.1) of the consensus LPS-binding motif are similarly positioned (Vandeputte- 
Rutten et a l ,  2001).
Some omptins have been found to be sterically inhibited by the 0-side chain of 
smooth LPS. For instance, recent studies have shown that 0-antigen in the outer core of
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LPS sterically inhibits Pla and PgtE proteins from cleaving larger substrates (Kukkonen 
et a l ,  2004; Pouillot et a l, 2005). S. typhimurium reduces the length o f its 0-antigen and 
regulates the expression of pgtE  during its intracellular growth in macrophages 
(Lahteenmaki et a l ,  2005). In E. coH, OmpT targets short peptides that are small enough 
to avoid steric hindrance from 0-antigen. In Y. pestis, the 0-antigen is not made due to 
mutations in genes encoding for the biosynthesis o f the 0-antigen pathway (Kukkonen et 
a l,  2004). Finally, in S. flexneri, it remains unclear whether Shigella modulates its LPS 
or whether LPS affects the proteolytic activity of IcsP.
3.1.4 Roles o f  omptins in bacterial pathogenesis 
Omptin proteins are a family of enterobacterial proteases that share high sequence 
identity. They have a variety of roles that are predominantly involved in bacterial 
virulence and function as proteases, adhesins, or invasins (Stathopoulos, 1998; Kukkonen 
et a l ,  2004). Intriguingly, the omptins have a wide array o f functions, yet the catalytic 
amino acids are completely conserved (Table 3.2). The expansive pathogenic roles and 
functions may be attributed to the minor sequence variations within the extracellular 
loops and/or the cellular background in which the omptin resides. This section highlights 
the known roles of omptins and the functions they serve in host environments.
3.1.4.1 OmpT o f  Escherichia coli 
OmpT, encoded by a cryptic lambdoid phage on the chromosome, is an outer 
membrane protease found in E. coli. It is detected in both nonpathogenic (e.g., K12) and 
human uropathogenic E. coli strains (UPEC). In the UPEC strains, OmpT is reported to 
cleave protamine PI, an antimicrobial peptide that is secreted by epithelial cells of the 
urinary tract (Marrs et a l , 2002). Host cells secrete protamine in order to kill invading
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bacterial cells. Protamine acts on the bacterial cytoplasmic membrane and causes 
membrane permeabilization, ultimately creating a large pore in the bacterial membrane 
(Aspedon et a l ,  1996; Johansen et a l ,  1997). It is thought that the cleavage of protamine 
by OmpT results in shorter peptide fragments that are physically unable to destabilize the 
bacterial membrane. Consequently, cleavage of protamine by OmpT protects E. coli 
from the bactericidal effects of this antimicrobial.
3.1.4.2 Pla o f  Yersinia pestis
Pla is a surface protease found in Y. pestis. Bacteria that express Pla are highly 
virulent yielding an LD50 increase o f 10  ̂fold in the absence of Pla (Sodeinde et a l, 1992; 
Sebbane et al., 2006). Sebbane et a l (2006) have shown that the expression of Pla is 
essential for establishment of pneumonic and bubonic plague. One o f the major roles of 
Pla is to enhance bacterial migration through tissue barriers, ultimately leading to the 
bacterial spread from a subcutaneous infection site (Kukkonen et a l ,  2004). This process 
is described in Figure 3.2. Pla proteolytically cleaves an abundant circulating zymogen, 
plasminogen and consequently activates it into plasmin. The function of plasmin in host 
cells is to degrade extracellular matrices and fibrin clots that form barriers that hinder 
bacterial migration. Pla also inactivates the antiprotease, a 2-antiplasmin (Lahteenmaki et 
a l,  1998; Kukkonen et a l, 2004) (Figure 3.2). (%2-antiplasmin functions to tightly control 
the amount o f plasmin in the host by deactivating free plasmin. Thus, the overall effect 
of Pla in the host is to degrade tissue barriers, which facilitates bacterial dissemination 
through host tissue.
Pla has been shown to cleave C3 protein o f the complement system on the 
bacterial surface (Sodeinde et a l , 1992). Since C3 is one of the significant players in the
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Figure 3.2: Overview of m am m alian plasminogen system and the effects of Y. pestis 
Plasminogen is an abundant circulating precursor that is proteolytically activated into 
plasmin. Plasmin is a serine protease that degrades fibrin clots (fibrinolysis) and 
extracellular matrices (ECM) that form barriers for cellular migration. Pla o f Y. pestis 
intervenes with the system (in red) by activating plasminogen into plasmin and 
inactivating ai-antiplasmin. The overall effect is bacterial migration through tissue 
barriers.
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complement activation cascade, its deactivation leads to the reduced production of 
chemoattractants and subsequent suppression of local inflammation. Another function of 
Pla, independent o f its proteolytic activity, is its ability to adhere to basement membrane 
preparations, extracellular matrix and human epithelial cells (Kukkonen et a i, 2004; 
Hritonenko et a i,  2007). Bacterial cell attachment to host tissues contributes to a 
persisting bacterial infection.
3.1.4.3 PgtE o f  Salmonella typhimurium 
PgtE is a chromosomally encoded outer membrane protease o f S. typhimurium. 
PgtE, like Pla can activate plasminogen to plasmin, which degrades fibrin clots and 
extracellular matrices o f eukaryotic tissues and allows for bacterial dissemination (Guina 
et a i ,  2000; Navarre et a i,  2005). Furthermore, previous work has shown that 
Salmonella PgtE expression promotes resistance to a-helical cationic antimicrobial 
peptides (CAMPs) (Guina et a i ,  2000). CAMPs are a major component of the innate 
immune response and are part o f the phagocytic vacuole o f macrophages and neutrophils 
(Zasloff, 1992). These peptides are involved in a complex interplay between mammalian 
host cells and microorganisms at epithelial surfaces. The role of cationic antimicrobial 
peptides is to kill bacteria by permeabilizing their membrane. However, Salmonella uses 
the activity o f PgtE to circumvent the immune defenses by cleaving CAMPs (Guina et 
a i , 2 0 0 0 ), preventing the formation o f large pores within the bacterial membrane and 
therefore protecting Salmonella against these antimicrobial compounds.
3.1.4.4 IcsP o f  Shigella flexneri 
IcsP, an outer membrane protease, is encoded by a monocistronic gene on the 230 
kb virulence plasmid in S. flexneri. The only known function of IcsP is to cleave a
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virulence determinant, IcsA, between Arg?;^ and Arg7S9 and release a -95  kDa fragment 
of IcsA from the bacterial surface (Egile et a l ,  1997) (Figure 3.3). Substitution o f either 
Arg759 or both Arg7S8 and Arg7S9 results in loss of cleavage (Fukuda et a l ,  1995). 
Experiments indicate that IcsP functions to maintain IcsA exclusively at the bacterial 
pole, where IcsA recruits host actin and allows for intracellular movement (Steinhauer et 
a l,  1999). In the absence of IcsP, there is an alteration in the distribution o f surface IcsA. 
In these icsP mutants, the typical tight polar cap of IcsA is not maintained. Thus, it has 
been proposed that IcsP functions to prevent diffusion o f IcsA in the outer membrane 
(Steinhauer et a l ,  1999). Egile et a l (1997) characterized the phenotype o f Shigella icsP 
mutants by analyzing the formation of plaques on confluent monolayers o f Caco-2 cells. 
Cell monolayers were infected with wild-type Shigella and an icsP mutant. Results 
showed that the icsP mutant formed as many plaques as the wild-type strain but plaque 
sizes were smaller. To date, studies on IcsP have focused primarily on its role in 
modulating the amount and distribution of IcsA and consequently actin-based motility. 
Since IcsP is regulated by known virulence gene activators and has high similarity to 
other omptins, we hypothesize that there are additional functions o f IcsP.
3.1.5 Transcriptional activators, VirF and VirB regulate the expression o f  icsP 
The pathogenicity of Shigella is a complex phenomenon, which requires the 
coordinated expression of several genes located both on the virulence plasmid and on the 
chromosome. The virulence plasmid contains a 31 kb region termed the entry region, 
which encodes proteins required for invasion o f host colonic epithelial cells, intra- and 
intercellular spread, and secretion o f the invasion proteins via a type III secretion 
apparatus. Located on the virulence plasmid are two regulatory genes, virF and virB.
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Figure 3.3: Schematic representation of IcsA and the IcsP cleavage site.
The letters under the cleavage site bar indicate the amino acid sequences containing the 
IcsP cleavage sites near the bacterial surface. IcsP cleavage of lesA occurs between 
Arg75 8-Arg7 5 9 . SP, signal peptide.
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VirF, a member o f the AraC family of transcriptional activators, is required for 
transcription of virB (Sakai et al., 1986; Tobe et al., 1993). VirB, a member o f the ParB 
family of partitioning proteins is necessary for transcription o f many genes clustered in 
opérons including ipa, mxi/spa, and icsP (Buysse et al., 1987; Andrews et a i, 1991; 
Wing et a i ,  2004). Expression of genes on the virulence plasmid, such as VirF and VirB 
has been shown to be thermoregulated (Maurelli et al., 1984). H-NS, a global regulator, 
has been shown to direct the temperature-regulated expression o f virulence genes by 
repressing their transcription during growth at 30°C (Dorman et a l ,  1990). The current 
model for temperature-dependent regulation suggests that at temperatures lower than 
37°C, H-NS represses transcription by preventing the binding of the positive regulator, 
VirF to target promoters. At 37°C, changes in DNA conformation at the promoters of 
virF and virB lead to an increased transcription of virF and to the activation of the virB 
promoter by VirF (Dorman et a i,  2001). Subsequently, production o f VirB leads to 
activation o f the icsP promoter (Wing et al., 2004) and the promoters of entry region of 
virulence plasmid genes (Adler et a i,  1989; Beloin et a i, 2002; Beloin et a i,  2003).
Previous work has shown that lesP expression is undetectable in mutants lacking 
either of two transcriptional activators, VirF and VirB (Wing et a i ,  2004). Expression of 
virB was found to be entirely dependent on VirF (Tobe et a i, 1993). Wing et a i  (2004) 
showed that VirB significantly enhanced icsP transcription, even in the absence o f VirF, 
suggesting VirB or a VirB-regulated gene product enhances transcription of the icsP 
gene.
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3.1.6 A small RNA, RyhB suppresses transcriptional activator VirB in S. dysenteriae 
Iron is one o f the most essential metals in the metabolism of bacteria because it 
serves as a eofactor in multiple enzymatic reactions (Masse et al., 2007). Consequently, 
bacteria have evolved mechanisms to acquire iron for these essential metabolic processes. 
One mechanism for iron acquisition involves the inactivation o f a global iron-responsive 
transcriptional repressor, the ferric uptake repressor protein (Fur). Fur binds to specific 
DNA sequences called Fur boxes, usually located in the promoter region o f a target gene 
(Gruer et a l ,  1994). The binding of Fur to Fur boxes is iron dependent and this in turn 
blocks access o f the RNA polymerase to the promoter of many iron acquisition genes. 
Conversely, the inactivation of Fur in the absence of iron results in the derepression of 
iron acquisition genes and ultimately, the uptake of iron (Figure 3.4 A).
Fur also represses RyhB. RyhB, a non-coding RNA first identified in E. coli, is a 
small regulatory RNA molecule that down regulates a set o f iron-storage and iron-using 
proteins when iron is limiting (Masse et a l ,  2002). In high iron conditions. Fur is 
activated and results in the repression of ryhB, which allows for the activation of iron 
storage genes. In low iron conditions. Fur does not bind to ryhB and consequently, RyhB 
is able to repress iron storage genes.
RyhB has been shown to decrease the stability o f specific transcripts when it 
binds to the complementary nucleic acid sequence within the target mRNA molecule 
(Vecerek et a l ,  2003). Once RyhB is bound to the target mRNA, this complex is 
degraded, which is mediated by RNase E and RNase III (Masse et a l ,  2003). Previous 
work has shown that suppression of S. dysenteriae virulence occurs via RyhB-dependent 
repression o f the transcriptional activator, VirB (Murphy et a l,  2007) (Figure 3.4 B).
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Figure 3.4: Iron  regulation in Shigella
A. Model o f Fur and RyhB interaction to regulate iron utilization
B. Model of Fur, RyhB, and VirB interaction to regulate virulence
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Repression o f virB leads to the reduced expression of certain genes within the VirB 
regulon, suggesting that all or most genes in the VirB regulon will be down regulated. 
However, this remains to be tested.
3.2 Materials and Methods
3.2.1 Bacterial strains, growth media, growth 
Bacteria were grown as single colonies by streaking glycerol stocks onto agar 
plates containing antibiotics, where appropriate and incubating at 37°C overnight. Liquid 
cultures were prepared by inoculating sterile media containing antibiotics, where 
appropriate, with a single colony from an agar plate and then incubating at 37°C with 
aeration. Bacterial strains used in this study are listed in Table 3.3. S. flexneri strains 
were routinely grown in TSB. E. coli and S. typhimurium strains were routinely grown in 
LB medium. Antibiotic concentrations used were as follows: ampicillin, 100 p-g mL ‘; 
chloramphenicol, 25 pg mL kanamycin 45 pg mL ' for TG61; kanamycin 50 pg mL ' 
for EHKOl and TMS02. All experiments were performed in triplicate.
3.2.2 Plasmid constructions 
Plasmids used in this study are listed in Table 3.4.
3.2.2.1 Construction o f  pEH K l9, pgtE in pBAD33 
To construct pEHK19, pgtE  was amplified from CS022 with oligonucleotides 9 
and 10 (Table 3.5). The PCR product was digested with Xm al and H indlll and ligated to 
linearized ATna/, //m£////pBAD33. To confirm the correct sequence o f pgtE  in pBAD33, 
pEHK19 was sequenced by Nevada Genomics Center.
6 2
Table 3.3 - Bacterial Strains
Strain Relevant Genotype Source
E. coli
DHIOB K-12 cloning strain Invitrogen
DH5a K-12 cloning strain Invitrogen
MBG263 MC1061 AowpT-.Kan'^ Goldberg & Theriot 
1995
MC1061 F' araD139 A(ara-leu) 7696 galElS  
galK16 A(lac) X74 rpsL (Str^) 
hsdR2 (rk- mk+)mcrA mcrBl
Meissner et a l ,  1987
S. typhimuHum
CS022 pho-24 (PhoP constitutive) Miller et a/., 1990
TG61 CS022 ApgtExKan"^ Guina et al., 2000
S. flexneri
2457T Wild-type serotype 2a Labrec et a l,  1964
2457T-Aw^ 2457T-Awg;, Congo Red negative Carter et a i, 2007
M90T Wild-type serotype 5 Sansonetti et a l,  1982
BS109 2457T ga/[/;;Tn70 Maurelli et a l,  1985
MBG341 2457T AicsP:: Amp*^ Shere et a l,  1997
AWY3 2457T AvirB\:Tn5 Wing et a l,  2004
MBG283 2457T A/c5y4::Spec'^ Steinhauer et a l, 1999
TMS02 2457T Awzyv.Yiar^ This work
EHKOl MBG341 Aw/^xRan'^ This work
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Table 3.4 - Plasmids
Plasmid Relevant Genotype Reference/Source
IcsP Roles Study 
pAJH02 pBAD33-/c.s/* This work
pBAD33 Cloning vector Stratagene
pEHK19 pBADhh-pgtE This work
pMBG270 pBR322-/c5^ Magdalena & Goldberg, 
2 0 0 2
icsP Regulation Study
pHJW20 icsp::lacZ Unpublished data
pryhB ^QE-2-ryhB Murphy et a l, 2007
pQE-2 Expression Vector Murphy et a i, 2007
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Table 3.5: Oligonucleotides - 5' to 3'
Oligo 9 CCTCATTCGCCCGGGTGACAAGATGAAA
ACTTCATCACC
Amplify pgtE  off 
CS022, Forward
Oligo 10 CGAATGAGGAAGCTTCCGGTTATGACCG
ATGACATCCCG
Amplify pgtE  off 
CS022, Reverse
Oligo 21 CCTCATTCGCCCGGGCTTATAAAGTAAG
AAGATCATGG
Amplify icsP off 
pHJW 6 , Forward
Oligo 22 CGAATGAGGAAGCTTGCCATGAAAACG
TAATCAACTCGG
Amplify icsP off 
pHJW6 , Reverse
Oligo 58 GGAAGTTAAGGCGGAAAAAGGCTG Amplify wzy, Forward
Oligo 59 CCCTATTTTTAACATCCTTTATTTTGCTC
CAG
Amplify Reverse
Oligo 11 GCCATCACAGGAAGCAGCCTC Amplify icsA, Forward
Oligo 12 GCCATCACAGGAAGCAGCCTC Amplify icsA, Reverse
Oligo 13 GGATATAGAAGAGCGGTTTG Amplify virK, Forward
Oligo 14 ACTTTATAATTTCAAGGGTACGGGTCCG Amplify virK, Reverse
Oligo 15 GCACTTTGTGTACCTGCGATC Amplify icsP, Forward
Oligo 16 GCACTATTTTTAATGGTGCCAG Amplify icsP, Reverse
Oligo 17 CGAATCGCTGCAGGATATTATGATGCTG
GAGTTTTGCGAAGC
Amplify virF, Forward
Oligo 18 CGAATCGAATTCCCATCTGGCAATAGCG
ATGGGC
Amplify virF, Reverse
Oligo 19 CGAATCGAATTCTGAATTGGGCAGTTTA
CATCAGTG
Amplify virB, Forward
Oligo 20 CGAATCGCTGCAGATTCTCTTTCTCTGAT
TGAAATGCTGG
Amplify virB, Reverse
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3.2.2.2 Construction o f  pAJH02, icsP in pBAD33 
To construct pAJH02, icsP was amplified from pHJW6  with oligonucleotides 21 
and 22 (Table 3.5). The PCR product was digested with H indlll and X m al and ligated to 
linearized Xmal, H indlll pBAD33. To confirm the correct sequence o f icsP in pBAD33, 
pAJH02 was sequenced by the Nevada Genomics Center.
3.2.3 Strain Constructions
3.2.3.1 Construction ofTM S02 and EHKOl
3.2.3.1.1 Preparation o f  transducing lysates
To prepare transducing lysates, 2457T-Awg; (Congo Red negative), the donor 
strain was grown overnight in tryptic soy broth containing kanamycin, 45 pg ml '. The 
following day, the cultures were back diluted (1:100) to an ODeoo 0.5-1.0. 0.25 M CaCh 
was added to the cultures and incubated for five minutes at 25°C. PI phage stock, 6  xlO^ 
PFU ml ' was added to the donor strains and incubated for two minutes at 25°C. Cells 
lysed after vigorous shaking at 37° C for three hours. Chloroform was added and 
incubated for 5 minutes at room temperature. Cultures were then centrifuged for two 
minutes at 12,800 x g  at 25°C. The supernatant was transferred to a new tube and 
chloroform was added and ultimately stored at 4°C.
3.2.3.1.2 P I transduction 
To create TMS02 and EHKOl, 2457T and MBG341 (recipient strains) were 
grown overnight in L broth medium without CaCl^. The following day the cultures were 
back diluted (1:100) into L broth medium supplemented with 2.5 mM CaCb to a density 
o f 2 X 10* cells ml ' at 37°C. Phage lysates were added to the recipient strains in L broth 
containing 2.5 mM CaC12 to achieve MOIs o f 0, 0.5, 2.5, and 10 and incubated at 25°C
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for 30 minutes to allow for absorption. One ml o f L broth medium, supplemented with 
50 mM sodium citrate was added to each mixture and incubated for one hour at 37°C. 
Cells were then centrifuged at 12,800 x g  for two minutes and the pellet was resuspended 
in 100 pi o f 1 M sodium citrate. Cells were ultimately spread on minimal medium with 
appropriate antibiotics.
To determine whether resultant colonies were transductants carrying the 
interrupted gene, oligonucleotides 58 and 59 were used to amplify the yvzy locus by 
PCR (Table 3.5). To determine whether the wzy mutants still contained significant 
virulence genes, 5 loci were verified by PCR amplification, virB, virF, virK, icsP, icsA 
using oligonucleotides pairs 11, 12; 13, 14; 15, 16; 17, 18; and 19, 20 (Table 3.5).
2.2.4 Determining cleavage o f  IcsA by IcsP in S. flexneri, western blot analysis 
To show that IcsP cleaved IcsA in 5. flexneri, 2457T (wild-type), MBG341 
IIASIT-AicsP), and MBG283 ilASlT-AicsA) carrying pMBG270 (icsA) were grown 
overnight in TSB medium. The following day, cultures were back-diluted (1:50) in TSB 
medium to an ODeoo 0.4-1.0.
Whole cell proteins were prepared from this culture by harvesting equivalent 
number o f cells and hence protein. Samples were then centrifuged at 12,800 x g  at 4°C 
for two minutes. The pellets were resuspended in 0.2 M Tris (pH 8.0) at 4°C in half of 
the original harvested volume. The samples were then centrifuged at 12,800 x g  at 4°C 
for two minutes. The supernatants were discarded and the pellets were resuspended in 
200 pi 10 mM Tris (pH 7.4) plus 50 pi 4X SDS-PAGE loading buffer containing |3- 
mercaptoethanol.
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To harvest the supernatant proteins, the supernatants were passed through a 0.22 
pM filter and precipitated with 10% (v/v) trichloroacetic acid. The samples were 
centrifuged at 12,800 x g  for 10 minutes at 4°C, washed with cold 95% (v/v) ethanol, and 
re-centrifuged for 5 minutes at 12,800 x g. The pellets were resuspended in 200 pi of 10 
mM Tris (pH 7.4) and 5 mM MgS0 4  and 50 pi 4X SDS-PAGE loading buffer containing 
(3-mercaptoethanol.
The whole cell and supernatant protein preparations were loaded onto a 10% (v/v) 
SDS-polyacrylamide gel and separated by electrophoresis at 30 mA. Proteins were then 
transferred to polyvinylidene fluoride (PVDF) membrane for two hours at 150 mA. The 
PVDF membrane was blocked with IX PBS containing 5% (w/v) non-fat powdered milk 
overnight at 4°C. The following day, the PVDF membrane was probed with a rabbit 
IcsA polyclonal antibody (1:10,000) for two hours at 37°C, washed with IX 
PBS/Tween-20 for 15 minutes three times, and incubated with the secondary antibody, 
anti-rabbit IgG, horseradish peroxidase linked F(ab’)̂  fragment from donkey (1:10,000) 
for one hour at 25°C. The membrane was washed with PBS/Tween-20 for 15 minutes 
three times. IcsA was detected by ECL kit (Amersham) according to the manufacturer’s 
instructions and visualized on a Typhoon scanner using ImageQuant Software.
3.2.5 Determining cleavage o f  IcsA by OmpT in E. coli, western blot analysis
To determirie whether OmpT cleaved IcsA in E. coli, pMBG270 (full-length icsA) 
was introduced into M CI061 (wild-type E. coll) and MBG263 (MC1061-Aow/?7) by 
electroporation. Cultures were grown overnight in LB medium, containing ampicillin, 
100 pg mL"'. The following day, cultures were back-diluted (1:50) in the LB medium for
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3.5 hours. Whole cell and supernatant proteins were prepared as previously described in 
section 3.2.4 and subjected to western blot analysis.
3.2.6 Determining cleavage o f  IcsA by PgtE in Salmonella, western blot analysis
To determine whether PgtE cleaved IcsA in Salmonella, pMBG270 (full-length 
icsA) was introduced by electroporation into CS022 (wild-type Salmonella) and TG61 
(CS022-Apg/£). Cultures were grown overnight in LB medium. The following day, 
cultures were back diluted (1:50) in LB medium for 3.5 hours. Whole cell and 
supernatant proteins were prepared as previously described in section 3.2.4 and subjected 
to western blot analysis.
3.2.7 Determining cleavage o f  IcsA by PgtE in S. flexneri, western blot analysis
To determine whether PgtE cleaved IcsA in S. flexneri, pEHK19 (pBAD33-pgt£) 
was introduced into MBG341 (2457T-A/c.sP). Cultures were grown overnight in TSB, 
supplemented with glucose, 0.02% (w/v) and chloramphenicol, 25 pg mL"'. The 
following day, cultures were back-diluted (1:50) in the TSB medium, lacking glucose, to 
an ODeoo 0.4-1.0 and subsequently induced with 0.2% (w/v) L-arabinose for one hour at 
37°C. Whole cell and supernatant proteins were prepared as previously described in 
section 3.2.4 and subjected to western blot analysis.
3.2.8 Determining whether IcsP and PgtE promote resistance to cationic antimicrobial 
peptide (CAMP), LL-37 in Shigella and Salmonella, respectively
Minimum inhibitory concentrations (MlCs) of CAMPs, required to kill 
Salmonella and Shigella cells either encoding or lacking omptins, were measured using 
bacterial sensitivity assays with the following strains: Salmonella spp. (CS022, wild-type; 
TG61, CS022-Apg/£) and Shigella spp. (2457T,wild-type; MBG341, McsP-, TMS02,
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Awzy\ EHKOl, AwzyAicsP). Shigella cultures were grown overnight in minimal medium 
containing: Na2HP0 4 , KH2PO4 NaCl, NH4 CI, casamino acids, nicotinic acid, tryptophan, 
thiamine, 2 mM CaCl2 , and 10 mM MgS0 4  and appropriate antibiotics. Salmonella 
cultures were grown overnight in N minimal medium containing: 5 mM KCl, 7.5 mM 
(NH4 )2 S0 4 , 0.5 mM K2 SO4 , 1 mM KH2PO4 , thiamine, casamino acids, 10% (v/v) 
glycerol, and 10 mM MgCb and the appropriate antibiotics. The following day, cultures 
were diluted to 2 x 10  ̂ bacteria per ml in N minimal medium or minimal medium. Test 
peptide, LL-37 was assayed at final concentrations of 10 pg per ml to 320 pg m f' in 96- 
well microtiter plates. The MICs were determined as the lowest concentration of the 
peptide that did not allow visible bacterial growth after 18 hours.
3.2.9 Bacterial strains, growth media, growth 
Bacteria were grown as single colonies by streaking glycerol stocks onto agar 
plates containing antibiotics, where appropriate and incubating at 37°C overnight. Liquid 
cultures were prepared by inoculating sterile media containing antibiotics, where 
appropriate, with a single colony from an agar plate and then incubating at 37°C with 
aeration. Bacterial strains used in this study are listed in Table 3.3. S. flexneri strains 
were routinely grown in TSB. Antibiotic concentrations used were as follows: 
ampicillin, 100 pg m L ' and chloramphenicol, 25 pg mL' .  All experiments were 
performed in triplicate.
3.2.10 Determining IcsP expression levels in RyhB-expressing Shigella cells,
western blot analysis 
To determine whether RyhB decreased IcsP expression levels, pryhB or pQE2 
was introduced into 2457T (wild-type) and AWY3 (2457T-Av/>R). Cultures were grown
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overnight in TSB medium. The following day, cultures were back diluted (1:50) to an 
ODôoo 0.4-1.0, and induced with 200 pM IPTG for one hour at 37°C.
Whole cell proteins were prepared from this culture by harvesting equivalent 
number o f cells and hence protein. Samples were then centrifuged at 12,800 x g  at 4°C 
for two minutes. The pellets were resuspended in 0.2 M Tris (pH 8.0) at 4°C in half of 
the original harvested volume. The samples were then centrifuged at 12,800 x g  at 4°C 
for two minutes. The supernatants were discarded and the pellets were resuspended in 
200 pi 10 mM Tris (pH 7.4) plus 50 pi 4X SDS-PAGE loading buffer containing p- 
mercaptoethanol.
The whole cell protein preparations were loaded onto a 12.5% (v/v) SDS- 
polyacrylamide gel and separated by electrophoresis at 30 mA. Proteins were then 
transferred to poly vinylidene fluoride (PVDF) membrane for two hours at 150 mA. The 
PVDF membrane was blocked with IX PBS/5% (w/v) milk overnight at 4°C. The 
following day, the PVDF membrane was probed with a rabbit IcsP polyclonal antibody 
(1:25) for two hours at 37°C, washed with PBS/Tween-20 for 15 minutes three times, and 
incubated with the secondary antibody, anti-rabbit IgG, horseradish peroxidase linked 
F(ab’)̂  fragment from donkey (1:10,000) for one hour at 25°C. The membrane was 
washed with PBS/Tween-20 for 15 minutes three times. IcsP was detected by ECL kit 
(Amersham) according to the manufacturer’s instructions and visualized on a Typhoon 
scanner using ImageQuant Software.
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3.2.11 Determining icsP promoter activity levels in RyhB-expressing Shigella cells, ^
galactosidase assay using a PicsP::lacZ fusion
Transcription from the icsP promoter was determined by measuring p-
galactosidase activity. 2457T pryhB pHJW20 (icsP::lacZ), 2457T pQE2 pHJW20,
AWY3 pryhB pHJW20, and AWY3 pQE2 pHJW20 were grown overnight in tryptic soy
broth containing the appropriate antibiotics. The following day, 5 ml o f tryptic soy broth
was inoculated with 150 pi of overnight culture and grown to an ODôso 0.3-0.6. Cells
were lysed with the addition o f a drop of toluene and a drop of 1 % (v/v) deoxycholate.
The sample was vortexed and aerated for 20 minutes at 37°C to eliminate the toluene.
The reaction was started by the addition o f 100 pi o f lysates to a mixture o f 1.9 ml Z
buffer and 0.5 ml of ONPG solution. When a yellow color had developed at 25°C, the
reaction was stopped by adding 1 ml o f IM  Na2CÜ3 solution. The tube was vortexed and
the OD420 was measured. Each set o f reactions was repeated three times and the mean p-
galactosidase activities were calculated. The P-galactosidase activity o f the cell lysate
was calculated using the following equation:
Activity = ODd?n x 1000 x 2.5 \  3.5 nmol / m in / mg bacterial mass 
O D fis o  X 4.5 X t X V
2.5 = conversion factor to convert ODôso into mg bacterial mass based on the 
assumption that an ODeso o f 1 corresponds to 0.4 mg bacterial mass ml '.
3.5 = total assay volume after addition of IM Na2CÜ3
1 0 0 0  / 4.5 = conversion factor to convert OD420 of a 1 nmol ml ' solution of 
ONPG in a 1 cm light path is 0.0045 
t = time in minutes 
V = volume of lysate added in ml
3.2.12 Media
Liquid and solid media were prepared by dissolving the specified quantities of 
reagents in distilled water.
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3.2.12.1 Tryptic Soy Broth Medium (TSB) (per liter): As described in section 
2 .2.8. 1.
3.2.12.2 Luria-Bertani (per liter): As described in section 2.2.8 .2.
3.2.12.3 Z buffer (per liter): 0.75g KCl, 0.25g MgS0 4  • 7 HzO, 8.5g Na2HP0 4 , 4.9g
NaH2P0 4  ■ 2 H2O, 2.7 ml p-mercaptoethanol
3.2.12.4 A Buffer (per liter): 11.6 g K2 HPO4 , 4.54g KH2PO4
3.2.12.5 ONPG: 13 mM in A buffer
3.2.12.6 Minimal Medium: 40 mM Na2HP0 4 , 17 mM KH2PO4 , 8.5 mM NaCl, 18.6
mM NH4CI, 0.4% (w/v) glucose, 0.4% (w/v) casamino acids, 0.01 mg ml ' 
nicotinic acid, 0.01 mg ml ' tryptophan, 0.01 mg ml"' thiamine, 0.1 mM 
CaCl2 , 0.5 mM MgS0 4
3.3 Results and Discussion
3.3.1 OmpT and PgtE cleave IcsA differently than IcsP 
To characterize the proteolytic activity of omptin proteases found in Shigella 
(IcsP), E. coli (OmpT), and Salmonella (PgtE), experiments were conducted to determine 
whether these proteases recognized and cleaved one substrate, IcsA in a similar manner. 
IcsA, a known substrate o f IcsP was introduced into Shigella, E. coli, and Salmonella, on 
a medium copy plasmid, pMBG270. IcsA and its cleavage products found in whole cell 
and supernatant protein preparations from Shigella, E. coli and Salmonella were 
compared and analyzed by western blot analysis.
3.3.2 IcsP cleaves IcsA 
Previous work has shown that IcsP cleaves IcsA (Egile et al., 1997). To confirm 
this observation, whole cell and supernatant proteins of two Shigella strains: 2457T 
(wild-type) and MBG341 {lASlT-AicsP), were compared (Figure 3.5). In whole cell 
protein extracts of both wild-type Shigella and the Shigella icsP mutant, full-length IcsA
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Figure 3.5: IcsP cleaves IcsA in Shigella cells and results in a ~95 kDa IcsA 
fragm ent.
2457T (wild-type) and MBG341 (2457T-A/c^P) were grown overnight and back-diluted 
(1:50) to an ODeoo 0.4-1 .0 . Equivalent amounts of proteins were loaded by normalizing 
the harvest volume to cell density. Whole cell and supernatant proteins were separated 
by SDS-PAGE, and transferred to a PVDF membrane. IcsA was detected by 
immunoblotting with an anti-IcsA antibody. A lower level o f IcsA was present in wild- 
type Shigella revealing that IcsP cleaves IcsA. A ~95 kDa IcsA fragment was present in 
the supernatant from wild-type Shigella cultures and absent in the supernatant from the 
icsP mutant cultures. Collectively these data show that IcsP cleaves IcsA and removes a 
~95 kDa fragment off the bacterial surface.
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protein (-125 kDa) was observed, however, less IcsA was observed in the wild-type 
strain (Figure 3.5, lane 1) than in the Shigella icsP mutant (Figure 3.5, lane 2). In the 
supernatant protein extracts, a -95 kDa IcsA fragment was present in samples 
collectedfrom cultures o f wild-type Shigella (2457T) (Figure 5, lane 3), but nothing was 
detectable in samples collected from the Shigella icsP mutant (MBG341) (Figure 5, lane 
4). Collectively, the decrease in the amount o f IcsA in whole cell protein preparations of 
wild-type Shigella and the presence o f a -95 kDa fragment only in the supernatant 
protein preparations of wild-type Shigella indicates that IcsP cleaves IcsA. These data 
are consistent with previous observations.
3.3.3 Multi-copy IcsA is cleaved by IcsP in a similar manner to native IcsA
Having confirmed that IcsP cleaves IcsA, our goal was to assess whether other 
omptins cleave IcsA. To do this we first chose to examine how IcsA is cleaved when it is 
expressed in a variety o f omptin containing bacteria. Since IcsA is unique to Shigella, we 
chose to express IcsA from a medium copy plasmid in each of the strains to be tested.
As a starting point for this work, we first chose to examine whether IcsA, 
expressed from a medium-copy plasmid, was cleaved by IcsP in a similar manner to that 
observed in our previous experiments. These experiments would allow us to assess 
whether expression of IcsA from a multi-copy plasmid overwhelmed the Shigella 
protease or not. To do this, pMBG270 {pBK322-icsA) was introduced into MBG283 
(2457T-A/c.Sy4). Cells were grown in similar conditions, whole cell and supernatant 
protein preparations were normalized to cell density, separated by SDS-PAGE, analyzed 
by western blot and IcsA levels were compared to those observed in wild-type Shigella 
(2457T) (Figure 3.6). In whole cell protein extracts, a -125 kDa IcsA band was present
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Figure 3.6: IcsP cleaves IcsA expressed from  pMBG270 in Shigella cells and  results 
in the release of ~95 kDa IcsA fragm ent, sim ilar to wild-type.
pMBG270 (icsA) was introduced into a Shigella strain: MBG283 (2457T-A/c5'A). 
Equivalent amounts of proteins were loaded by normalizing the harvest volume to cell 
density. Whole cell and supernatant proteins were separated by SDS-PAGE, and 
transferred to a PVDF membrane. IcsA was detected by immunoblotting with an anti- 
IcsA antibody. IcsA, expressed from pMBG270, is cleaved by IcsP in a similar manner 
to IcsP cleaving natively expressed IcsA.
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in both wild-type Shigella (2457T) and MBG283 pMBG270 (Figure 3.6, lanes 1 and 2). 
Additionally, cleavage o f native IcsA and non-native IcsA, expressed from pMBG270, 
resulted in a -95 kDa fragment appearing in the supernatant protein extracts of both 
strains (Figure 3.6, lanes 3 and 4). These data suggest that although IcsA was expressed 
from a multi-copy plasmid in these experiments, the Shigella protease was not 
overwhelmed and retained its ability to cleave its substrate. Overall, these experiments 
confirmed that the plasmid system could be used to examine cleavage of IcsA by the 
other omptin proteases.
3.3.4 OmpT cleaves IcsA differently than IcsP 
To determine whether the E. coli omptin, OmpT recognizes and cleaves IcsA in a 
similar manner to the other omptins, whole cell and supernatant protein extracts from two 
E. coli strains: M CI061 (wild-type) and MBG263 (MCI06I-Aowp7) each carrying 
pMBG270 (icsA) were examined. Whole cell and supernatant protein extracts were 
normalized to cell density, separated by SDS-PAGE, and analyzed by western blot 
(Figure 3.7). Strikingly, IcsA was absent in whole cell protein extracts of wild-type E. 
coli (Figure 3.7, lane 1) and present in whole cell protein extracts o f an E. coli ompT 
mutant (Figure 3.7, lane 2). In the supernatant protein extracts o f wild-type E. coli, an 
-85 kDa was present (Figure 3.7, lane 3), but IcsA was not detected in the supernatant 
protein extracts o f the E. coli ompT mutant (Figure 3.7, lane 4). Collectively, these data 
suggest OmpT cleaves IcsA, resulting in an -85 kDa IcsA fragment which is released 
into the growth medium (Figure 3.7, lane 3 and 4). Furthermore, when compared to the 
results observed in Shigella, these data indicate that OmpT cleaves IcsA in a dissimilar 
marmer to IcsP. It is important to note that these E. coli strains contain a second omptin
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Figure 3.7: OmpT cleaves IcsA in E. coli cells and results in an ~85kDa IcsA 
fragment.
pMBG270 (icsA) was introduced into these two E. coli strains: MC1061 (wild-type) and 
MBG263 (MC1061-Aom/?7). Equivalent amounts of proteins were loaded by 
normalizing the harvest volume to cell density. Whole cell and supernatant proteins were 
separated by SDS-PAGE, and transferred to a PVDF membrane. IcsA was detected by 
immunoblotting with an anti-IcsA antibody. IcsA is present in whole cell protein 
preparation in an E. coli strain lacking OmpT. However, IcsA cannot be detected in 
wild-type E. coli. In an E. coli strain containing OmpT, a -85 kDa IcsA band is detected 
in the supernatant protein preparations.
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protease, OmpP, however, OmpP is not likely expressed in these conditions (glucose- 
replete) because it is regulated by the cyclic AMP system (Kaufmann et a l, 1994). 
Consequently, OmpP should not interfere or compound the proteolytic activity of OmpT 
in these experiments.
3.3.5 PgtE cleaves IcsA differently than IcsP and OmpT
Next, to examine whether the Salmonella omptin, PgtE recognizes and cleaves 
IcsA in a similar manner to the other omptins, whole cell and supernatant protein extracts 
from two Salmonella strains: CS022 (constitutive phoP) and TG61 (CS022-Apg/£) each 
carrying pMBG270 {icsA) were examined. Previous work has shown that PgtE is 
regulated by PhoP/PhoQ activation system (Guina et a l ,  2000). Consequently, these 
Salmonella mutants constitutively express PgtE. Whole cell and supernatant protein 
extracts were normalized to cell density, separated by SDS-PAGE and analyzed by 
western blot (Figure 3.8). IcsA was not detected in whole cell protein extracts of wild- 
type Salmonella (Figure 3.8, lane 1), but a -125 kDa IcsA and was present in the whole 
cell protein extracts of a Salmonella pgtE  mutant (Figure 3.8, lane 2). These data 
resemble our observations made in the E. coli strains. In supernatant protein extracts of 
wild-type Salmonella, two fragments (-85 kDa and -95kDa) were present (Figure 3.8, 
lane 3), but IcsA was not detected in supernatant protein extracts o f the Salmonella pgtE  
mutant (Figure 3.8, lane 4). Together, these data suggest that PgtE cleaves IcsA, 
resulting in two fragments being released into the growth medium (Figure 3.8, lanes 3 
and 4). Moreover, PgtE cleaves IcsA differently that IcsP and OmpT.
These experiments show that the omptins tested recognize and cleave IcsA 
differently. Yet, it remained unclear whether the altered pattern o f IcsA cleavage was a
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Figure 3.8: PgtE cleaves IcsA in Salmonella cells and results in two IcsA fragments.
pMBG270 {icsA) was introduced into these two Salmonella strains: CS022 (wild-type) 
and TG61 {CS022-ApgtE). Equivalent amounts of proteins were loaded by normalizing 
the harvest volume to cell density. Whole cell and supernatant proteins were separated 
by SDS-PAGE, and transferred to a PVDF membrane. IcsA was detected by 
immunoblotting with an anti-IcsA antibody. Two bands, a ~95 kDa and ~85 kDa, are 
present in the supernatant from CS022. IcsA was not detected in the supernatant from 
TG6 I cultures.
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result of amino acid differences in the surface loops o f the omptins and/or LPS binding 
region o f the proteins or whether the different cellular backgrounds, and more 
specifically the LPS composition of these different strains, influence the specificity of 
activity o f these proteases (described further in section 3.1.3). To determine whether the 
LPS composition affected the cleavage of IcsA, an omptin switching experiment was 
conducted. The Salmonella omptin pgtE  was introduced in a Shigella icsP- background 
and IcsA and IcsA cleavage products were analyzed. We hypothesized that if  the 
Salmonella cellular background affected the activity of PgtE to recognize and cleave 
IcsA, then Shigella cells expressing PgtE, would cleave IcsA in a dissimilar manner. 
However, if  the IcsA banding pattern were the same in both conditions tested, the most 
likely explanation for the different cleavage pattern of IcsA would be inherent differences 
in the amino acid residues of the extracellular loops and/or the LPS binding region of the 
PgtE protein, leading to alteration o f its substrate recognition and/or site specificity and 
hence its cleavage of the substrate IcsA.
3.3.6 Multi-copy IcsP cleaves IcsA similar to native IcsP 
To determine whether the pattern of IcsA cleavage was similar in strains carrying 
medium-copy icsP to that seen in strains carrying the native copy o f this gene, pAJH02 
(pBAD33-icsP) was introduced in a Shigella background carrying an interrupted icsP 
gene, MBG341 IIASIT-AicsP). Gene expression from pAJH02 was induced with 0.2% 
(w/v) L-arabinose for one hour, and whole cell and supernatant proteins were analyzed. 
In whole cell protein extracts of both wild-type Shigella and the Shigella icsP mutant 
(MBG341), each carrying pAJH02, full-length IcsA (-125 kDa) was observed, however, 
less IcsA was observed in the wild-type strain (Figure 3.9, lanes 3 and 4). In the
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Figure 3.9: IcsP, expressed from pAJH02, cleaves IcsA in MBG341, similar to wild- 
type Shigella.
pAJH02 (pBAD33-/cj'/y was introduced into Shigella: MBG341 (2457T-A/c5P) and 
induced with 0.2% (w/v) L-arabinose for one hour at 37° C. Samples were normalized to 
total and supernatant protein, separated by SDS-PAGE, and transferred to a PVDF 
membrane. IcsA was detected by immunoblotting with an anti-IcsA antibody.
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supernatant protein extracts o f MBG341, carrying pAJH02 (induced), a -95  kDa 
fragment was present (Figure 3.9, lane 5), but nothing was detectable in samples 
collected from the non-induced cells (figure 3.9, lane 6 ). This showed IcsA is cleaved by 
IcsP and is released into the supernatant. This was similar to what was observed in wild- 
type Shigella expressing icsP (Figure 3.9, lanes 1 and 2). Overall, the inducible-plasmid 
system reflected similar banding patterns seen in wild-type Shigella cells expressing 
native IcsP.
S.J. 7 The cellular environment does not affect the proteolytic specificity o f  PgtE 
The next question we sought to address was: Does the LPS environment 
surrounding the omptin influence its activity or site specificity? To address this, pEHK19 
(pBAD33-pgtE) was introduced in an icsP Shigella mutant, MBG341 (2A51T-AicsP) and 
pgtE  was expressed using conditions described above for icsP. In whole cell protein 
extracts, IcsA was not detected in cells expressing pgtE  (Figure 3.10, lanes 1 and 2), 
whereas IcsA was present as a -125 kDa band in cells not expressing pgtE  (non-induced 
pEHK19), cells containing the empty expression vector, either induced or non-induced 
(Figure 3.10, lanes 3, 4, and 5). In supernatant protein extracts of cells expressing multi­
copy pgtE, two fragments o f IcsA (-85 kDa and -95 kDa) were detected in cells 
expressing pgtE  (Figure 3.10, lanes 6  and 7), but IcsA was not detected in supernatant 
proteins of cells not expressing multi-copy pgtE  (Figure 3.10, lanes 8 , 9, and 10). When 
IcsA fragments from Shigella cells expressing PgtE (Figure 3.10) were compared to those 
detected in Salmonella cells expressing PgtE (Figure 3.8), IcsA was found to be cleaved 
in a similar manner. Collectively, these data suggest that the cellular background does 
not affect the proteolytic specificity o f PgtE. It is also possible that there is no difference
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Figure 3.10: PgtE cleaves IcsA in Shigella ceils and results in two IcsA fragm ents.
pEHK19 (pBAD33-/?gt£) and pBAD33 (empty vector) were induced and non-induced for 
one hour at 37°C with 2% (w/v) or 0.2% (w/v) L-arabinose in a Shigella background, 
MBG341 {2457T-AicsP). Samples were normalized to total protein and supernatant 
protein, separated by SDS-PAGE, and transferred to a PVDF membrane. IcsA was 
detected by immunoblotting with an anti-IcsA antibody. IN, induced; NI, non-induced. 
Two bands, a -95  kDa and -85 kDa, are present in the supernatant from MBG34I. No 
IcsA was detected in the supernatant o f Shigella containing the empty vector.
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in the LPS of Salmonella and Shigella with the growth conditions used. Moreover, these 
results suggest that the observation that the omptins cleave IcsA differently is likely 
caused by the amino acid differences present in the surface loops of the active site and/or 
the LPS binding motif.
3.3.8 Omptin fam ily conclusions
Although the catalytic amino acids are completely conserved among IcsP, OmpT, 
and PgtE, it is clear that these proteases cleave IcsA differently, as judged by western blot 
analysis. These differences seen in IcsA-cleavage can be attributed to the differences in 
amino acid residues within the surface loops of the active site and in the LPS binding 
motif. When comparing amino acid residues in the surface loops of IcsP, OmpT, and 
PgtE, a difference is found at residue 223 (comparison of surface loops in 3D homology 
models in Figures 3.1 and 3.11). In OmpT, serine, an uncharged polar amino acid, is 
found at residue 223, and the corresponding amino acids in IcsP and PgtE are aspartic 
acid, a negatively charged polar amino acid and glutamic acid, a negatively charged polar 
amino acid, respectively. The inherent amino acid differences at this residue in the 
surface loops may contribute to differences observed in the proteolytic specificity among 
these omptins.
The activity o f omptin proteases has been found to be dependent on the presence 
of LPS (Kramer et al. , 2000). Kramer et al. (2002) examined the affect o f LPS on the 
enzymatic activity o f OmpT. Results showed that the refolding of OmpT into its active 
form required the addition of LPS. Consequently, any amino acid modification within 
the LPS binding motif may alter the specificity and activity of IcsP, OmpT, and PgtE. 
When comparing the LPS binding region of IcsP to OmpT, one amino acid difference is
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Figure 3.11: IcsP homology model to OmpT.
Predicted 3D structure of IcsP. The IcsP homology model was created using 
MEME/MAST software by Christian Ross.
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found at. residue 175. In OmpT, arginine, a positively charged amino acid is present in 
the LPS binding region and the corresponding amino acid in IcsP is leucine, a nonpolar 
amino acid. This amino acid change may affect the proteins interaction with the LPS and 
hence its structure, thereby altering the proteolytic specificity o f IcsP with respect to 
OmpT.
Additionally, the Salmonella omptin, PgtE, requires LPS to be proteolytically 
active (Kukkonen et a l ,  2004). Previous work has shown that substitution o f Argus and 
Argni of the LPS protein binding motif abolished proteolytic activity, suggesting that 
PgtE requires LPS for enzymatic activity (Kukkonen et a l ,  2004). When comparing the 
LPS binding region of PgtE to IcsP, there are two amino acid differences. In IcsP, an 
amino acid, leucine, a nonpolar amino acid is present and the corresponding amino acid 
found in PgtE is arginine, a positively charged polar amino acid. The other amino acid 
difference is lysine, a positively charged polar amino acid in IcsP to glutamic acid, a 
negatively charged polar amino acid in PgtE. Consequently, these amino acid differences 
may alter the conformation and placement of IcsP and PgtE within the LPS, thereby 
affecting their proteolytic specificity for IcsA.
3.3.9 PgtE promotes resistance to cationic antimicrobial peptide,
LL-37 in Salmonella and Shigella 
It has been shown that some o f the omptins specifically cleave between paired 
basic residues and after a basic residue that is followed by a nonpolar amino acid 
(Sugimura et a l, 1988). Consequently, cationic antimicrobial peptides are potential 
targets for PgtE and IcsP. Moreover, previous work has shown that PgtE promotes 
resistance to antimicrobial peptides, C I 8 G and LL-37 in Salmonella (Guina et a l,  2000).
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To determine whether IcsP promotes resistance to cationic antimicrobial peptide 
LL-37, minimum inhibitory concentration (MIC) assays were conducted. To determine 
whether our MIC assays worked properly, resistance of wild-type Salmonella (CS022), 
compared to a Salmonella pgtE  mutant (TG61) was tested initially to determine whether 
PgtE promotes resistance to LL-37 in Salmonella, diS shown previously (Guina et a l,  
2000). Our results show that in the pgtE  mutant strain (TG61) there was increased 
sensitivity to LL-37, 10 p,g m l'' when compared to wild-type Salmonella in which PgtE 
appeared to promote resistance to LL-37, 80 fxg ml"' (Table 3.6).
3.3.10 IcsP does not promote resistance to cationic antimicrobial peptide,
LL-37 in Shigella
We next examined whether IcsP, the outer membrane protease o f Shigella, could 
promote resistance to LL-37. MICs of wild-type Shigella (2457T) and a Shigella icsP 
mutant (MBG341) were compared. The Shigella icsP mutant did not show increased 
sensitivity to LL-37, 30 pg ml"' when compared to wild-type Shigella, 30 pg pi"', 
suggesting that IcsP does not protect Shigella from LL-37 (Table 3.6).
Previous studies have shown that the 0-side chain o f smooth lipopolysaccharide 
may sterically inhibit the activity o f omptins. An example o f steric inhibition by the O- 
antigen, affecting the proteolytic activity, has been shown in Pla and PgtE (Kukkonen et 
a l,  2004; Pouillot et a l ,  2005). Additionally, 0-antigen modulation in reduction and 
mutations in genes encoding for the biosynthesis of the 0 -antigen pathway have been 
found in Salmonella and Yersinia, respectively. It is possible that the long 0-antigen side 
chains o f EPS may hinder the proteolytic activity of IcsP. Moreover, the lengths of the 
0-antigen side chains of Shigella in an in vivo and in vitro system are not well-
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Table 3.6. MICs of cationic antimicrobial peptide, LL-37
Strain Genotype
M IC (pg/ml) 
LL-37
Salmonella
CS022 wild-type Salmonella 80
TG61 CS022-ApgtE 1 0
TG61 pBAD33 CSQ22-ApgtE, parental expression vector 
Induced
80
TG61 pBAD33 CS022-ApgtE, parental expression vector 
Non-induced
80
TG61 pAJH02 CS022-ApgtE, pBAD32-icsP 
Induced
80
TG61 pAJH02 CS022-ApgtE, pBAD33-icsP 
Non-induced
80
Shigella
2457T wild-type 30
MBG341 2457T-A/C5P 30
TMS02 2457T-Awzy 1 0
EHKOl 2457T-Ah'^ -A ;c5P 1 0
EHKOI pAJH02 2A51Y-Awzy-AicsP, pBAD3 3 -/C5 P 
Induced
80
EHKOl pAJH02 2A511-Awzy-AicsP, pBAD33-/cj'P 
Non-induced
80
MBG34I 2A511-AicsP, parental expression vector 160
pBAD33 Induced
MBG34I 2A51T-AicsP, parental expression vector 160
pBAD33 Non-induced
MBG341 2A511-McsP, pBAD33-pgÆ 320
pEHK19 Induced
MBG341 2A51T-AicsP, pBAD33-pgtE 160
pEHK19 Non-induced
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characterized. Consequently, we created Shigella 0-antigen polymerase (wzy) mutants, 
which produce only one 0-antigen side chain, to determine whether IcsP could promote 
resistance to LL-37 in a Shigella background.
When comparing MICs of a Shigella wzy mutant (TMS02) to a Shigella wzy, icsP 
mutant (EHKOl) in the antimicrobial resistance assay, EHKOl did not show increased 
sensitivity to LL-37, 10 pg ml ' (Table 3.6) when compared to TMS02, 10 pg pi '. To 
further examine the role of IcsP in resistance to LL-37, icsP was introduced in EHKOl on 
an L-arabinose inducible plasmid (pAJH02). MICs of cells expressing icsP and cells not 
expressing icsP in EHKOl were compared. Again, the MICs of -expressing and 
/c5 P-nonexpressing Shigella were the same. Take together, these data suggest that IcsP 
does not promote resistance to a-cationic antimicrobial peptide, LL-37.
We next examined whether the cellular background was affecting the proteolytic 
activity o f IcsP by conducting omptin-switching experiments. PgtE was introduced in a 
Shigella background and IcsP was introduced in a Salmonella background to determine 
whether each promoted resistance to LL-37 in a non-native background. pgtE  (pEHK19) 
was expressed in a Shigella icsP mutant (MBG341) and compared to a non-expressing 
pgtE Shigella icsP mutant. PgtE protected Shigella (MBG341) from the bactericidal 
effects o f LL-37 2-fold higher (320 pg m l'') than a Shigella icsP mutant not expressing 
PgtE (160 pg m l'') (Table 3.6). However, IcsP did not protect Salmonella from the 
bactericidal effects of LL-37. icsP (pAJH02) was expressed in a Salmonella pgtE  mutant 
(TG61) and compared to a non-expressing icsP Salmonella mutant. IcsP did not promote 
resistance to LL-37 in a Salmonella background, 80 pg pi '. These data suggest that the 
resistance to LL-37 is affected by the inherent differences between omptins rather than
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the LPS environment influencing the activity of the protein. This is most likely a result 
o f amino acids differences present in the surface loops, or it is possible that differences in 
LPS binding motif may influence the activity of the omptins.
3.3.11 RyhB does not affect IcsP expression levels or icsP promoter activity
Previous work has shown that RyhB represses the expression o f several genes 
within the S. dysenteriae VirB regulon (Figure 3.6 B) (Murphy et a l ,  2007). 
Additionally, VirB, a transcriptional activator, has been shown to regulate the expression 
of icsP (Wing et a l,  2004). Consequently, we wanted to determine whether RyhB 
regulated the expression of IcsP. ryhD was expressed in Shigella strains lacking virB and 
IcsP protein levels and transcriptional activity from the icsP promoter were measured. 
IcsP levels were compared in Shigella wild-type (2457T) and virB mutant strains 
(AWY3) each expressing ryhB from an IPTG inducible plasmid (pryhB), or carrying the 
vector control (pQE2) (Figure 3.12, top). Additionally, IcsP levels were compared in 
Shigella wild-type (2457T) and virB mutant strains (AWY3), each containing icsP 
(pHJW6 ) and expressing ryhB from an IPTG inducible plasmid (pryhB), or carrying the 
vector control (pQE2). icsP was introduced on a low-copy plasmid in Shigella cells 
expressing ryhB because differences in IcsP protein levels may not be detected with 
native IcsP protein levels. Overall, there was no detectable difference in IcsP protein 
levels in Shigella expressing ryhB from uninduced Shigella strains and ry/?5-expressing 
Shigella carrying the vector control (Figure 3.12, bottom). IcsP was not detected in the 
Shigella icsP mutants (AWY3) as predicted because of the absence o f virB, a known 
transcriptional activator o f icsP. Taken together, these data suggest that RyhB does not 
decrease the protein levels of IcsP.
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2457T AWY3
38-
26
pryhB 
IN NI
pQE2
IN NI
pryhB 
IN NI
pQE2 
IN NI
2457T AWY3 2457T AWY3
pryhB, pHJWG pQE2, pHJWe
IN NI IN NI IN NI IN NI
Figure 3.12: RyhB does not decrease IcsP expression levels.
pryhB, pQE2 , pryhB and pHJW6 , or pryhB and pQE2 were introduced into Shigella: 
2457T (wild-type) and AWY3 (2457T-Av/>5). Samples were normalized to total protein, 
separated by SDS-PAGE, and transferred to a PVDF membrane. IcsP was detected by 
immunoblotting with an anti-IcsP antibody. IN, induced with 200 p,M IPTG for 1 hour at 
37°C; NI, not induced.
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To examine the effect o f RyhB on icsP transcription, we measured |3- 
galactosidase production from an icsP-lacZ transcriptional reporter (pHJW20) in wild- 
type Shigella (2457T) and a Shigella virB mutant (AWY3). Transcription from the icsP 
promoter was measured in wild-type and virB mutant Shigella strains, each carrying 
pryhB or the vector control, pQE2. When ryhB was induced in each strain, transcription 
from the icsP promoter was not significantly different from the non-induced ryhB strains 
(Table 3.7). These data suggest that RyhB does not decrease icsP transcription.
Although RyhB has been shown to suppress many genes encoded on the VirB 
regulon, the molecular mechanism of RyhB-dependent repression o f virB is not entirely 
clear. Murphy et al. (2007) did not find any significant complementarity between RyhB 
and virB mRNA, but suggested that that limited complementarity between these RNA 
molecules may be sufficient to mediate repression. Because o f the limited 
complementarity, it is possible that VirB is expressed at low levels and that VirB has a 
higher affinity for icsP than the affinity o f RyhB for virB. I f  the affinity of VirB for icsP 
is higher, then a difference in IcsP protein levels may not be detected.
3.4 Conclusions
This chapter addresses experiments that focus on three objectives. The first 
objective was to further enhance our knowledge o f members o f the omptin family. To 
characterize members of the omptin family, we examined whether three omptins, IcsP, 
OmpT, and PgtE recognized and cleaved a substrate, IcsA, in a similar manner. These 
experiments identified whether the cellular background or the amino acid differences 
present in the surface loops and/or LPS binding motif affected the proteolytic activity of
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Table 3.7; Activation of icsP-lacZ transcriptional fusions by RyhB
Strain Genotype*
p-Galactosidase expression 
(Miller units)
Fold 
activation 
(mean + 
SD) “
Uninduced Induced
2457T pryhB wild-type ryhB 5,467 5,846* NA
2457T pQE2 wild type vector control 4,999 6 ,2 1 0 * NA
AWY3 pryhB 2457T-Av/>5 ryhB 402 409* NA
AWY3 pQE2
2457T-Av/rJ5 vector 
control
395 514* NA
® AU strains carried pHJW20 (icsP-lacZ)
* There was no significant difference between uninduced and induced
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the omptins. The second objective was to determine whether the Shigella outer 
membrane protease, IcsP could promote resistance to cationic antimicrobial peptides. 
Finally, the third objective was to determine whether IcsP was regulated in a RyhB- 
dependent manner.
Our results revealed that IcsP of Shigella, OmpT of E. coli, and PgtE of 
Salmonella all cleave a substrate, IcsA, differently, as judged by western blot analysis. 
These results raised the question of whether the differences seen in IcsA cleavage were a 
result o f the differences in the amino acids present in the surface loops o f the active site 
or the cellular background in which these omptins reside. The omptin switching 
experiment addressed this question and revealed that the cleavage specificity of PgtE for 
IcsA remained the same in both a Salmonella and Shigella background. These results 
suggest that the cellular background is not influencing the differences observed in the 
cleavage of IcsA, but the amino acid differences present in the extracellular loops of the 
proteins were responsible for the differences in the proteolytic cleavage o f IcsA. It is also 
possible that the LPS of Salmonella and Shigella are not significantly different and that 
LPS may have an effect but carmot be detected. Although there are only one to two 
differences in the surface loops of the active site (Table 3.2, Figure 3.1) and LPS binding 
motif among the omptins found in E. coli. Salmonella, and Shigella, this work has shown 
that these slight differences can significantly affect proteolytic specificities o f a specific 
substrate (Figures 3.5 - 3.8). Additionally, the amino acid differences within the LPS 
binding motif may alter the conformation and placement o f the protein in the outer 
membrane, which can also affect the proteolytic specificity o f these proteases. From our 
results, we can conclude that the different cleavage specificities o f each protease is likely
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from the amino acid differences instead of the cellular background (Figures 3.8 and 3.10). 
It would be interesting to determine whether, in fact, the differences in IcsA cleavage are 
a result o f the amino acid differences by substituting key amino acids in the surface loops 
and the LPS binding motif to make these omptins more similar to each other.
As previously reported, the only known function of IcsP is cleavage and 
maintenance of IcsA at the bacterial pole. Because of the high sequence identity and the 
1 0 0 % conserved catalytic site with the other proteases o f the omptin family, it was 
suspected that IcsP might serve an additional role in Shigella pathogenesis. 
Consequently, the second objective was to determine whether IcsP could promote 
resistance to cationic antimicrobial peptides (CAMPs). One member of the omptin 
family, PgtE has been shown to promote resistance to a-cationic antimicrobial peptides 
by cleaving CAMPs into smaller fragments (Guina et al., 2000). Cleavage o f CAMPs 
into smaller fragments prevents the destabilization of the bacterial membrane. MICs of 
2457T (wild-type Shigella) were compared to MBG341 {2A511-AicsP). In these strains 
examined, no differences in MICs were observed. Our results showed that IcsP did not 
promote resistance to LL-37 in Shigella. These results raised the question of whether the 
cellular background was affecting the proteolytic activity o f IcsP. Studies have shown 
that LPS length can sterically inhibit the proteolytic activity of outer membrane proteases 
(Kukkonen et a l ,  2004). Consequently, we addressed this issue in two ways: using 
Shigella mutants that created only one 0-antigen side chain iyvzy) and conducting omptin 
switching experiments. MICs o f EHKOI (2457T-A/c5P Awzy) expressing icsP (pAJH02) 
were compared to EHKOl not expressing icsP. There was no difference in MICS 
observed. We also addressed this question by switching IcsP and PgtE from a Shigella
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into a Salmonella background. IcsP did not promote resistance in a Salmonella 
background. However, PgtE did promote resistance to LL-37 in a Shigella background. 
Our studies suggest that IcsP does not recognize LL-37 as a substrate and that this may be 
caused by the differences in the amino acids o f the surface loops o f the active site and/or 
the LPS binding region from PgtE. Only one antimicrobial peptide was used in this 
study. Previous work has shown that OmpT promotes resistance to protamine in E. coli 
(Stumpe et a l ,  1998). It would be interesting to examine whether IcsP can promote 
resistance to other antimicrobial peptides such as protamine.
RyhB has been shown to repress several genes within the S. dysenteriae VirB 
regulon. In S. flexneri, VirB derepresses icsP. Consequently, we hypothesized that 
increased levels of RyhB would result in decreased protein levels o f VirB and ultimately 
decreased protein levels and transcriptional activity of icsP. However, when comparing 
IcsP protein levels in RyhB expressing cells to uninduced cells, IcsP protein levels were 
the same. Furthermore, when determining the effect of RyhB on icsP transcription, there 
was no difference in icsP promoter activity in RyhB expressing cells from uninduced 
cells. Although RyhB has been shown to suppress many genes encoded on the VirB 
regulon, the exact mechanism of RyhB-dependent repression has not been elucidated. It 
would be interesting to examine whether icsP in an S. dysenteriae background is affected 
by RyhB-repression. It is also possible that the affinity of VirB for icsP is higher than the 
affinity o f RyhB for virB. This could reflect the results seen in the western blot analysis 
and |3-galactosidase assays.
Taken together these data shed light on members of the omptin family and allow 
us to better understand the specificity of a protease and the interaction of an outer
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membrane protein with its environment. Moreover, this work has focused specifically on 
a Shigella virulence plasmid-encoded protease, IcsP. It is important to highlight that the 
only ascribed function of IcsP is to cleave IcsA However, due to high similarity among 
other omptins, we hypothesize that there are additional roles and regulation of this key 
virulence determinant in Shigella. Whether there are additional roles, are yet to be 
elucidated. These studies expand our knowledge of the roles o f IcsP in pathogenesis and 
protein regulation. Ultimately, gaining knowledge of this significant key virulence factor 
better enables us to understand why this pathogen has acquired this protease and what 
function it has in the pathogenesis o f Shigella.
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CHAPTER 4 
CONCLUSIONS
Shigella spp. pose a major health problem worldwide warranted by the damaging 
dysentery that the bacteria may cause in humans. Research in the past 30 years has 
contributed to our understanding of shigellosis. This study further contributes to our 
knowledge of the molecular biology of these important pathogens. A thorough 
understanding of the molecular mechanisms underlying Shigella biology and 
pathogenicity is essential for the design of protective and prevention strategies, 
particularly ideal vaccine development. This section highlights the four main objectives 
addressed in this thesis and concludes with the overall significance and relevance of our 
findings.
4.1 Conserved mechanism of protein targeting in y-proteobacteria 
Accurate localization of proteins to specific spatial sites within bacterial cells is 
essential for many biological functions in bacteria. However, the mechanisms by which 
these proteins localize to their specific addresses are not completely understood. To 
acquire a better understanding of this process, we sought to determine whether the 
mechanism of polar targeting found in Shigella is conserved in three closely related 
families in the y-proteobacteria. We have concluded that the elusive mechanism of 
protein targeting used by this protein is conserved in the y-proteobacterial species
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investigated in this study (discussed in chapter 2). This study provides insight on this 
process and can essentially influence the development in prevention strategies against 
bacterial infections and disease.
4.2 Characterization of the omptin family 
Our second aim in this study was to further characterize omptin proteins found in 
three pathogenic organisms: Shigella (IcsP), E. coli (OmpT), and Salmonella (PgtE). It is 
not entirely clear how the LPS environment affects the activity of outer membrane 
proteases. Experiments described in chapter 3 of this thesis address whether the LPS 
environment and/or the inherent amino acid differences in the surface loops and LPS 
binding motif affect the cleavage specificity of three omptin proteases for a specific 
substrate. Understanding the activity and interaction between the omptin protease and 
their LPS environment allows us to dissect the interplay of these proteases with their 
environment. Although our results showed that the LPS environment might not affect the 
proteolytic activity of these proteases, further work is needed to clarify the complex 
relationship outer membrane proteases have with their cellular environment. The 
comparative approach described here using IcsP, OmpT, and PgtE has provided more 
clues about the proteolytic mechanism of these proteases. Ultimately these data could be 
used as a starting point of obtaining omptin-inhibiting drugs, and thus preventing severe 
infections and disease.
104
4.3 The roles and regulation of IcsP in Shigella flexneri
Our third aim in this study was to determine whether IcsP, an outer membrane 
protease, plays an additional role in the pathogenesis of S. flexneri by promoting 
resistance to cationic antimicrobial peptides. To date, the only known function for IcsP is 
cleavage of IcsA. However, the significance of IcsP in Shigella pathogenesis is not 
completely understood. Since it has been shown that the Salmonella homolog to IcsP, 
PgtE promotes resistance to cationic antimicrobial peptides, we hypothesized that IcsP 
may play a similar role in the pathogenesis of Shigella. Our results show that IcsP, at 
least under the conditions tested, does not promote resistance to a cationic antimicrobial 
peptide, LL-37 (discussed in chapter 3). However, its homolog, PgtE of Salmonella, 
does. Currently, it remains unclear whether IcsP promotes resistance to other 
antimicrobial peptides such as protamine. Moreover, there are additional roles such as 
cleavage of C3 of complement system and adhesion to human epithelial cells, for IcsP 
that have yet to be investigated.
The final aim of this study was to determine whether RyhB regulates the 
expression of icsP. RyhB is a regulatory RNA that suppresses a key virulence 
transcriptional activator, VirB. It has been suggested that the role of RyhB may be to 
coordinate and fine-tune the expression of S. dysenteriae virulence genes with the local 
concentration of iron (Murphy et al., 2007). Since VirB is required for maximal 
expression of icsP, we reasoned that RyhB may regulate icsP. To test this we examined 
icsP expression in the presence of multi copy RyhB. Our results suggested that RyhB 
does not down-regulate the expression of icsP in S. flexneri (discussed in chapter 3).
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However, further studies are needed to better understand whether iron and/or RyhB are 
involved in fine-tuning the expression of virulence genes in S. flexneri.
Ultimately, this work has attempted to improve our understanding of how IcsP 
functions. Moreover, IcsP can be a suitable target for antimicrobial drugs and vaccine 
development. Ultimately, the applied relevance of this study has potential use for the 
development of prevention and intervention strategies against shigellosis.
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